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CHAPTER 1 
INTRODUCTION 
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The first successful choledochotomy to remove stones from the common bile duct was 
performed on January 21, 1890, by Courvoisier but it was not until 1940 that the bile ducts 
could be explored with reasonable safety for the patient (I). 
Since then choledochotomy has become an accepted therapy for choledocholithiasis. 
However, it is accompanied by considerable morbidity and mortality, especially in elderly 
patients at increased operative risk and after acute surgery (2-6). 
There has always been much discussion whether to use intraoperative cholangiography 
routinely for the detection of common bile duct stones. Many pleas for its routine use can 
be found in the literature from about 1965 to 1975 (7-11). Since then, preference has moved 
towards the selective use of intraoperative cholangiography (12-15). 
From 1972, endoscopic incision of the papilla of Vater and subsequent removal of stones in 
the common bile duct became the therapy of choice in patients older than 50-60 years (16-
22). This age limit was originally chosen because at this age mortality from papillotomy and 
common bile duct exploration were about the same. The 10% of patients in whom endoscopy 
failed remained a problem (18,23-25). In these patients, extracOIpOreal shock wave 
lithotripsy (ESWL) seemed an attractive option before contemplating surgery (26-32). This 
alternative was evaluated in a series of 90 elderly patients treated by ESWL for difficult 
common bile duct stones. The results are described in chapter 2 of this thesis. 
In 1990, the first series oflaparoscopic cholecystectomy was reported (33). Never was a new 
surgical technique introduced so rapidly and in such an uncontrolled fashion as this operation. 
Because of its apparent advantages, laparoscopic cholecystectomy has become the treatment 
of choice for symptomatic gallbladder stones in almost all Western hospitals within a few 
years (34-37). However, the increased incidence of lesions of the bile ducts during this 
operation compared to open cholecystectomy, gives rise to concern (36,38-41). Patient 
selection and initial reports from centers with expert biliary surgeons have led to a very 
optimistic view on this operation (42). The increased incidence of choledochal repairs parallel 
to the introduction of the laparoscopic cholecystectomy provides evidence that the incidence 
of iatrogenic bile duct lesions is higher than reported. 
In chapter 3 we have tried to explore the advantages of the laparoscopic cholecystectomy in 
terms of quality of life. However, the only way to find out the real value of the laparoscopic 
cholecystectomy -a prospective, randomised controlled trial comparing laparoscopic 
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cholecystectomy with the open technique- has become practically impossible (43). This 
problem, which is partly consumer driven, led us to match the first 100 patients, who were 
operated laparoscopically in our hospital, with 100 conventionally cholecystectomized 
patients. This study is described in chapter 4. 
Since the introduction of the laparoscopic cholecystectomy, routine common bile duct 
exploration is no longer available, unless a conversion to open operation is undertaken. 
Laparoscopic exploration of the common bile duct is not yet generally feasible (44,45), so 
the important issue is to detect common bile duct stones in the preoperative phase and to treat 
them endoscopically. This strategy has been advocated recently and also patients younger 
than 50 years might be submitted to it (46-49). 
The discussion about the role of intraoperative cholangiography, now during laparoscopic 
cholecystectomy, has been revived (46-53). Its routine use could potentially protect patients 
from possible bile duct damage and preoperatively unsuspected stones in the common bile 
duct could be detected. However, to date it has not been possible to show that routine 
intraoperative cholangiography during laparoscopic cholecystectomy in fact prevents bile duct 
injury. In addition, the natural course of unsuspected -usually small- stones in the common 
bile duct probably is that about 90% of these stones will pass spontaneously, thus making it 
difficult to prove that detection of common bile duct stones will reduce complications 
(54,55). 
Chapter 5 is a review of the literature and deals with the management of stones in the 
common bile duct in the era of the laparoscopic cholecystectomy. Our results of 
extracorporeal shock wave lithotripsy .(ESWL) of common bile duct stones, as an adjuvant 
to laparoscopic and endoscopic techniques, are incorporated in this chapter. 
Obstruction of the pancreatic duct by stones is encountered less frequently than that of the 
common bile duct. Pancreatic duct obstruction by stones is almost exclusively the result of 
chronic pancreatitis, a disease which is largely due to chronic alcohol abuse (56,57). Stones 
causing increased intraductal pressure are probably a major cause of the severe invalidating 
abdominal pain in these patients. Surgical drainage procedures fail in the long term 
alleviation of pain in 20-40% of the patients (56,58-61). Taking into account the morbidity 
and mortality of pancreatic drainage procedures, ESWL of these intraductal stones provides 
an alternative with minimal morbidity and to date no mortality (62-66). 
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Chapter 6 describes the immediate and long term results of our first 17 patients with chronic 
calcifying pancreatitis treated by ESWL Also a case with an unusual indication for ESWL 
of pancreatic stones is described. 
As with almost all therapies, initial enthusiasm is tempered by subsequent disappointing 
results and enthusiasm is replaced by reservation and seepsis. Finally, often after many years 
of evaluation, the therapy gets the credit it deserves. We have tried to assess the role of 
ESWL in hepato-biliary-pancreatic surgery. Instead of very optimistic or pessimistic views, 
patients benefit most from well-established treatment schedules in which the different 
modalities all have their own, sometimes limited, role. In chapter 7 this role is described 
using our own patient series and those of other institutions. 
Finally, chanter 8 deals with malignant obstruction of the proximal bile ducts. Obstructive 
symptoms are almost always the presenting features of this tumor (67), that is called 
cholangiocarcinoma or 'K!atskin'-tumor (68). Although a slow growing tumor, more than 
90% of untreated patients die within 5 years after the diagnosis has been made, mostly due 
to recurrent cholangitis or hepatic failure (69). Sinee the development and improvement of 
various imaging techniques tumor staging can be done more accurately. For this reason a 
subpopulation of patients with cholangiocarcinoma, suitable for intentionally curative 
operations, can be more easily defined. Radical resection of the tumor seems to give the most 
hopefull results (70,71). We describe our multidisciplinary approach towards 66 patients with 
proximal cholangiocarcinoma and discuss the role of the various treatments and the 
importance of tumorfree resection margins after surgery. 
Chapter 9 discusses the various results and adds some closing remarks. 
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Aims of this study: 
What is the effectiveness of ESWL as a treatment for difficult bile duct stones in patients at 
increased operative risk? (chapter 2). 
Does laparoscopic cholecystectomy improve quality of life and biliary and gastrointestinal 
symptoms better than conventional cholecystectomy? (chapter 3). 
Is laparoscopic cholecystectomy superior to conventional cholecystectomy with regard to 
complications of both techniques? (chapter 4). 
Which diagnostic and treatment schedule can be followed when common bile duct stones are 
suspected in a patient who will undergo laparoscopic cholecystectomy? (chapter 5). 
Is ESWL a better option than operation to treat intractable pain in patients with chronic 
calcifying pancreatitis? (chapter 6). 
To what extend does ESWL playa role in todays' pancreatico-biliary surgery? (chapter 7). 
How can diagnosis and treatment of proximal cholangiocarcinoma be optimized? (chapter 8). 
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CHAPTER 2 
EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY OF STONES IN THE COMMON 
BILE DUCT IN PATIENTS AT INCREASED OPERATIVE RISK. 
R.L. van der Hul', P.W. Plaisier', M. van Blankenstein', O.T. Terpstra', R. den Toom', 
H.A. Bruiningl 
Department of Surgery, University Hospital Rotterdam, Rotterdam, The Netherlands (I) 
Section of Gastroenterology, University Hospital Rotterdam, Rotterdam, The Netherlands (2) 
Department of Surgery, University Hospital Leiden, Leiden, The Netherlands (3) 
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ABSTRACT 
Objective: Assessment of efficacy of extracorporeal shock wave lithotripsy (ESWL) of stones' 
in the common bile duct. 
Design: Prospective clinical study. 
Setting: Department of Surgery, University Hospital Rotterdam, Rotterdam, The Netherlands. 
Subjects: 90 patients with stones in the common bile duct and at increased operative risk 
(median age 73 years, range 27-95). 
Interventions: After failure of endoscopic measures, the first 13 patients were treated under 
general anaesthesia with a first generation lithotriptor. Of the next 77 patients, treated with 
a second generation lithotriptor, only one required general anaesthesia and 68 intravenous 
analgesia and sedation. Eight patients needed no analgesia at all. 
Main outcome measures: fragmentation, clearance, and recurrence of stones. 
Results: Fragmentation of stones was achieved in all the first 13 patients and 63 of the 
remaining 77. The stones were completely cleared in 62 of the 90 patients (69%). There 
were minor complications (macroscopic haematuria and subcapsular haematoma of right 
kidney) in 13 and serious complications (bacteraemia) in two. At follow-up (median 28 
months), two patients had recurrent stones. 
Conclusion: ESWL of stones in the common bile duct is safe and effective and should be 
considered in high risk patients. 
INTRODUCTION 
The first clinical use of extracorporeal shock wave lithotripsy (ESWL) was in the treatment 
of kidney stones (1), and since then it has been the treatment of choice. Other applications 
of ESWL were studied, and in 1986 Sauerbruch et al. reported successful fragmentation of 
stones in the gallbladder and in the common bile duct (17). In 1988 and 1989 the first series 
of patients were published in whom stones in the gallbladder and the common bile duct had 
been treated by ESWL (16,18). Promising results of ESWL of pancreatic stones have 
recently been published (3). 
Stones in the common bile duct can present as the first sign of gallstone disease or after 
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cholecystectomy wether or not the common bile duct was explored. About 9%-16% of 
patients with stones in the gallbladder also have choledocholithiasis (13). In the case of stones 
in the common bile duct, exploration is an accepted treatment but carries a considerable 
mortality, which reaches 8% in elderly or high risk patients (5,12,19). For this group 
nowadays the treatment of choice is endoscopic sphincterotomy (2,9,20). If the gallbladder 
is present, it is justified to leave it there after sphincterotomy, clearance of the common bile 
duct, and relief of symptoms (7,14). In about 10% of cases, however, it is not possible to 
remove the stones from the common bile duct (2,10,18), usually because of a discrepancy 
between the diameter of the stone and that of the bile duct, the presence of a (large) duodenal 
diverticulum, or signs of a previous upper abdominal operation, particularly a Roux-en-Y 
reconstruction. In these cases ESWL offers an attractive alternative to exploration of the 
common bile duct. 
We present our results of ESWL in 90 consecutive patients who had stones that could not be 
removed endoscopically from the common bile duct. 
PATIENTS AND METIIODS 
The entry criteria for treatment with ESWL are shown in table I. 
Table I 
Criteria for treatment of stones in the common bile duct by ESWL 
Symptomatic common bile duct stones Gaundice, abdominal pain, fever) 
Endoscopic extraction impossible 
Visualisation of stones by fluoroscopy after injection of contrast and 
successful positioning of the patient on the lithotriptor 
No lung tissue, cysts, or aneurysms in the path of the shock waves 
No bleeding disorders 
No pregnancy 
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Ninety patients were treated between April 1986 and July 1992. the first 13 with a first 
generation lithotriptor, the Dornier HM3' (with water bath). The remaining 77 were treated 
with a second generation lithotriptor, the Siemens Lithostar' (without water bath). The 
principles of generation of the shock waves for these two lithotriptors are different (6). The 
characteristics of the patients are shown in table II. 
Table II 
Characteristics of 90 patients with stones in the common bile duct before treatment by ESWL. 
Figures are number (%) of patients unless otherwise stated. 
Sex: 
Male 
Female 
Median (range) age (years): 
Symptoms: 
Upper abdominal pain 
Jaundice 
Cholangitis 
Sphincterotomy 
Drainage: 
Naso-biliary drain 
Percutaneous transhepatic drain 
T-tube 
Gallbladder in situ: 
No of stones: 
Solitary 
Two 
Three or more 
Intrahepatic stones 
Mean (range) diameter of largest stone (mm) 
33 (37) 
57 (63) 
73 (27-95) 
48 (53) 
44 (49) 
18 (20) 
79 (88) 
68 (76) 
II (12) 
II (12) 
42 (47) 
38 (42) 
21 (23) 
31 (34) 
8 (9) 
25 (10-50) 
The first 13 patients (treated with the Dornier lithotriptor) were given general anaesthesia. 
Of the next 77 patients, only one patient was given a general anaesthetic at his own request, 
68 were given only intravenous analgesia and sedation with fentanyl and midazolarn, and 
eight needed no analgesia at all. 
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The stones were visualised by injection of contrast medium (Telebrix 38', Guerbet, 
Gorinchem, The Netherlands) into the bile ducts (through an endoscopically placed 
nasobiliary drain, [n=68], or a percutaneous transhepatic drain [n=ll], or a T-tube left in 
after cholecystectomy [n= II]). The shock waves could then be focussed on the stones under 
fluoroscopic guidance. All patients were given antibiotic prophylaxis (1000/200 mg 
amoxycillin/clavulanate intravenously half an hour before ESWL, and 8 and 16 hours 
afterwards). The day after ESWL the amount of fragmentation was evaluated by a new 
cholangiogram. If there was no obvious reduction in the diameter of the largest stone the 
patient underwent up to four ESWL sessions. If the diameter of the stone had been reduced, 
or if there were other signs of fragmentation (lines of contrast medium visible within the 
stone or quick disappearance of the contrast medium from the biliary tree), the bile ducts 
were lavaged with four liters of sterile water124 hours through the biliary drain (saline was 
not used, to prevent overload of SOdium). After two days of lavage, a control cholangiogram 
was done and, in the case of the remaining fragments, further attempt was made to remove 
them endoscopically or percutaneously. If this was not successfull or if there was no 
fragmentation of stones, the patient had either an elective exploration of the bile duct or had 
an endoprosthesis inserted. The latter procedure was done if the patient had an unacceptably 
high operative risk. 
RESULTS 
Fragmentation and clearance of stones 
The mean (SEM) number of sessions of ESWL/patient was 1,8 (0,1) with 4360 (106) shock 
waves/session. The results are summarised in Figure L 
Fragmentation and subsequent clearance of stones was achieved in 62 patients (69%). In 15 
cases biliary lavage alone was sufficient to clear the bile ducts, though in 47 patients 
additional treatment was necessary. In 14 patients (16%) the stones were fragmented but we 
were unable to clear them. Six underwent successful endoscopic placement of an 
endoprosthesis past the fragmented stones. 
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Results of ESWL of 90 patients with common bile duct stones. 
Six underwent elective exploration of the common bile duct and two required emergency 
operations because of complications that developed during endoscopic attempts to clear the 
common bile duct (I perforation of the common bile duct with a Dormia basket, 1 arterial 
bleeding after extension of a sphincterotomy). These two recovered uneventfully. 
All patients in whom fragmentation by ESWL failed (n=14, 16%), underwent elective 
exploration of the common bile duct without complications. 
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Complications of ESWL 
Eleven patients (12 %) had transient macroscopic haematuria after ESWL, two patients (2 %) 
developed subcapsular haematoma of the right kidney shown on ultrasonography and one of 
these also had macroscopic haematuria. The haematomas resolved without clinical 
consequences. 
Despite antibiotic prophylaxis, two patients (2 %) developed bacteraentia with positive blood 
cultures (pseudomonas aeruginosa and Escherichia coli); both were treated sucessfully with 
antibiotics (piperacillin and gentamicin). 
Follow-up 
The median duration of follow-up (range) was 28 months (1-60). During this period six 
patients died of non-biliary causes and two others were lost to follow-up one and four months 
after ESWL, respectively. 
In two patients stones recurred in the common bile duct. One patient, aged 84 also had a 
gallbladder full of stones, and he was treated successfully with ESWL for the stones in the 
common bile duct. He was seen 27 months later with recurrent jaundice and abdominal pain 
and at endoscopic retrograde cholangiography (ERC) a stone 15 mm in diameter was 
removed from the common bile duct with a Dorrnia basket. 
The other high risk patient was 76 years old. He had had a cholecystectomy and then 
successful ESWL for stones in the common bile duct. He presented again 31 months later, 
with fever and abdominal pain and this time had an ERC at which four stones were seen in 
the common bile duct. He left hospital without complaints after repeated sessions of ESWL. 
To date, none of the other 80 patients have had any biliary symptoms or signs since their last 
treatment. 
DISCUSSION 
Since the introduction of endoscopic sphincterotomy, surgical exploration of the common bile 
duct has ceased to be the preferred treatment for stones in the common bile duct. Particularly 
in elderly or high risk patients, morbidity and mortality after cholecystectomy increase 
considerably if the common bile duct is explored at the same time (5,12,19), so endoscopic 
removal of stones from the bile duct is attempted as a primary procedure in these patients. 
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Nowadays most cholecystectomies are done laparoscopically. To preserve the minimally 
invasive character of laparoscopic cholecystectomy in the case of stones in the common bile 
duct, it is likely that the rate of endoscopic interventions before or after laparoscopic 
cholecystectomy will increase. As a result the number of patients in whom endoscopic 
removal of the stones fails will also increase. We can therefore expect a growing population 
of patients from whom the gallbladder has been removed laparoscopically but who have 
retained stones in the common bile duct, even after endoscopic sphincterotomy. Among this 
group there will be a considerable number of elderly patients (8) at increased operative risk 
and they are potential candidates for ESWL. This profile of the patient who is suitable for 
ESWL of stones in the common bile duct can be seen clearly in our own group of patients; 
more than half had already had the gallbladder removed and their mean age was high (Table 
II). 
Finally, we achieved complete clearance of the stones in the common bile duct in 69 % of our 
patients after ESWL together with endoscopic or percutaneous procedures. The alternative 
for these patients would have been an exploration of the common bile duct. 
An important point is that the first 13 patients were treated with a first generation lithotriptor, 
the Dornier HM3' (with water bath). We achieved a better fragmentation rate with this 
lithotriptor than with the second generation machine that we used thereafter (the Siemens 
Lithostar' without water bath). The shock waves for the two lithotriptors are generated in 
different ways (6), which accounts for the fragmentation rate of 100% with the first 
lithotriptor compared with 82 % for the second one, as there was no significant difference in 
the number of stones between the two groups. 
The patients treated with the first generation lithotriptor were all given general anaesthesia 
because we thought that the treatment would be too painful, but Lindstrom et al. (II) have 
recently reported good results using the Domier HM3 f lithotriptor without general 
anaesthesia. With the second generation lithotriptors, there is no need for general anaesthesia 
(one of our patients was given general anaesthesia at his own request). We saw macroscopic 
haematuria only in the patients treated with the first machine. One haematoma of the kidney 
occurred after treatment with each machine. 
We have achieved a fragmentation rate of 82 % and a clearance rate of 64 % with our present 
lithotriptor, which is similar to the results obtained by Nicholson et al. with the sarne 
lithotriptor (15). They achieved fragmentation in 44 of their 54 patients (81 %) with stones 
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in the common bile duct, and complete clearance of the duct in 38 (70%). Dobrilla et al. 
(4) recently reported their results with a similar second generation lithotriptor. They achieved 
fragmentation in 46 out of 49 patients (94 %) and complete clearance of the bile duct in 43 
(88%). They had a particularly aggressive protocol in their study and used a mean total of 
12 474 shock waves/patient (compared with 7848 shock waves/patient in our study). In 
addition, 67% of their patients had a single stone (compared with 42% in our study). To 
avoid the still considerable number of explorations of the duct after failure ofESWL, it could 
be argued that more aggressive ESWL should be undertaken, but this would be at the 
expense of more associated complications (in the study by Dobrilla et al. 8% of the patients 
had blood in the bile). The patients in our series whose stones did not fragment after ESWL 
had uneventful explorations of their bile ducts, which indicates that only a controlled study 
can exactly define the advantages and disadvantages of ESWL compared with exploration of 
the duct. 
Our rate of clearance tended to be better in patients who had single stones with smaller 
diameters, but this was not significant. Patients with a 'relative' distal stenosis of the 
common bile duct on ERe, however, seem to have less favourable clearance rates 
(unpublished observation) and this condition should be investigated further as a possible 
flegative prognostic factor in ESWL of stones in the common bile duct. 
The complication rate after ESWL is low. The two patients with bacteraemia after ESWL 
had already had cholangitis with periods of infection before the treatment. Nevertheless, 
serious morbidity and eventual mortality after endoscopic sphincterotomy or a percutaneous 
intervention must be borne in mind, because these procedures are essential adjuvants to 
ESWL treatment of stones in the common bile duct. 
We conclude that ESWL of stones in the common bile duct is a rapid, non-invasive, and 
effective treatment with minimal discomfort for the patient. In case endoscopic removal of 
the stones proves impossible, it should be tried before operation is undertaken, particularly 
in elderly or high hisk patients. 
27 
Reftjrence. .. 
I. Chaussy Ch. Brendel W. Schmiedt E. Extracorporeally induced destruction of kidney stones by shock 
waves. Lancet 1980;ii: 1265~8. 
2. Cotton PB. Endoscopic management of bile duct stones (apples and oranges). Gut 1984;25: 587-97. 
3. Delhaye M. Vandermeeren A, Baize M, et al. Shock wave lithotripsy of pancreatic calculi. 
Gastroenterology 1992;102: 610-20. 
4. Dobrilla G. Pretis G de, Felder M. et aI. Extracorporeal shock-wave lithotripsy in bile duct stones 
refractory to papillosphincterotomy. Eur 1 Gastroenterol & Hepatol 1992;4: 475-80. 
5. Doyle Pl, Ward-McQuaid lN, McEwen Smith A. The vaIue of routine preoperative cholangiography -
a report of 4,000 cholecystectomies. Br J Surg 1982;69: 617~19. 
6. Fenuci JT. Biliary lithotripsy: 1989 . .A1R 1989;153: 15-22.16. 
7. Hill J, Martin OF, Tweedle DEF. Risks of leaving the gallbladder in situ after endoscopic 
sphincterotomy for bile duct stones. Br J Surg 1991;78: 554-57. 
8. Huguier M, Bornet P, Charpak Y, et aI. Selective contraindications based on multivariate anaIysis for 
operative cholangiography in biliary lithiasis. Surg Gynecol Qbstet 1991;172: 470-4. 
9. John~n AG, Hosking SW. Appraisal of the management of bile duct stones. Br J Surg 1987;74: 555-
60. 
10. Lambert ME, Betts CD, Hill J, et aI. Endoscopic sphincterotomy: the whole truth. Br J Surg 1991:78: 
473-6. 
II. Lindstrom E, Borch K, Kullman EP, et aI. Extracorporeal shock wave lithotripsy of bile duct stont:S: 
a single institution experience. Gut 1992;33: 1416~20 
12. McSherry CK, Glenn F. The incidence and causes of death following surgery for non-malignant biliary 
tract disease. Ann Surg 19'80;191: 271-5. 
13. Nahrwold D. The biliary system. In: Sabiston D, 10th ed. Textbook of surgery. Philadelphia: WE 
Saunders, 1986. 
14. Neoptolemos JP, Davidson BR, Shaw DE. et aI. Study of common bile duct exploration and 
endoscopic sphincterotomy in a consecutive series of 438 patients. Br J Surg 1987;74: 916-21. 
15. Nicholson DA. Martin DF, Tweedle DEF. et aI. Management of common bile duct stones using a 
second-generation extracorporeal shockwave litbotriptor. Br J Surg 1992:79: 811-14. 
16. Sackmann M. Delius M. Sauerbruch T. et aI. Shock~wave lithotripsy of gallbladder stones. The first 
175 patients. N Eng! J Med 1988;318, 393-97. 
17. Sauerbruch T, Delius M, Paumgartner G, et al. Fragmentation of gallstones by extracorporea1 .to:k 
waves. N Engl J Med 1986;314: 818-22. 
18. Sauerbruch T, Stern M, and the study group for shockMwave lithotripsy of bile duct stones. 
Fragmentation of bile duct stones by extracorporeal shock waves. A new approach to biliary calculi 
after failure of routine endoscopic measures. Gastroenterology 1989;96: 146-52. 
19. Vellacott KD, Powell PH. Exploration of the common duct: a comparitive study. Br J Surg 1979;66: 
389-91 
20. Zimmon DS. Alternatives to cholecystectomy and common ductexploration. Am J Gastroenterol 
1988;83, 1272-3. 
28 
ADDENDUM: 
at the time of writing this thesis, the median follow-up of 100 patients treated by ESWL for 
their bile duct stones, had considerably augmented: four patients were lost to follow-up. 
Twenty patients died with a median follow-up of 20 months (range: 2-62). In 18 cases this 
was not related to biliary causes. One patient died of acute cholangitis 2 months after 
unsuccessful ESWL. Another patient had recurrent stones in the common bile duct 29 months 
after ESWL and he died of complications of a surgical bile duct exploration performed 
elsewhere. Of the remaining 76 patients the median follow-up is now 3 years (range: 2-83 
months). As already mentioned, two of these patients developed recurrent stones at 27 and 
31 months follow-up, respectively. Both of them were again treated successfully by ESWL 
and endoscopic extraction. At last follow-up, none of the other 74 patients experienced 
recurrent biliary symptoms after their final treatment. 
Another interesting feature of ESWL is that it can be used for the management of impacted 
Dormia baskets: Among our patients there were 6 with an impacted Dormia basket as a 
complication of the initial endoscopic treatment. Four of them were successfully treated by 
ESWL; the stone in the basket was fragmented and subsequently, the basket could be 
removed. The fifth patient developed a common bile duct lesion after an attempt to retract 
the basket. At the subsequent operation a fragmented stone was found in the basket. In the 
sixth patient the stone could not be fragmented and she underwent a choledochotomy for 
removal of stone and basket. 
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ABSTRACT 
A prospective study was set up to compare the quality of life and the course of biliary and 
gastrointestinal symptoms after laparoscopic cholecystectomy (LC) and conventional 
cholecystectomy (CC). 
Fourteen patients underwent LC and 17 patients CC. Quality of life questionnaires and 
symptom profiles were taken before and at 3, 6, 12, 18 and 24 months after operation. Pain 
diaries covered the periods 0-3, 3-6, 6-12 and 12-18 months. Median follow-up was 12 and 
24 months for LC and CC, respectively. 
Quality of life signiflCantly improved after 6 months in the LC-group and to a similar degree 
after 12 months in the CC-group. Bloating, fat intolerance and nausea improved significantly 
at 3, 6 and 6 months after LC and at 6, 18 and 24 months after CC, respectively. Vomiting 
and belching had a tendency to improve slightly, while pyrosis, constipation and diarrhoea 
did not improve in either group. Biliary pain was relieved in 81 % of the patients (25/31) 
directly after cholecystectomy and was no longer reported in any patient 6 months after 
operation. 
Cholecystectomy improves quality of life and cures nausea, fat intolerance, bloating and 
biliary pain. LC improves quality of life and symptomatology to the same degree but at an 
earlier stage than CC. Therefore, from the point of view of quality of life and early relief of 
abdominal symptoms, LC is preferable to CC for the treatment of uncomplicated symptomatic 
gallstones . 
INTRODUCTION 
Any form of elective surgery is directed primarily to improvement of quality of life, i.e. the 
relief of disability, discomfort and disfigurement [1,2]. Especially in the treatment of 
symptomatic gallstones, improving the patient's quality of life should be the most important 
aim of the intervention [3]. We studied the effects of cholecystectomy on the quality of life. 
We also studied its effects on biliary and gastrointestinal symptoms. Finally, we studied 
differences between the effects of laparoscopic cholecystectomy as compared to conventional 
cholecystectomy, the gold standard [4,5]. 
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PATIENTS AND METHODS 
Thirty one patients with uncomplicated, symptomatic biliary stone disease were recruited from 
,a surgical outpatient biliary clinic, in the period January 1990 - January 1993. Patients were 
diagnosed as 'symptomatic' according to the Roma Working Team-definition [6]. With this 
definition, symptomatic stone disease is characterized by acute biliary pain involving one or 
more episodes of abdominal pain (usually epigastric or right upper quadrant) lasting more than 
15 minutes but less than five hours. Biliary complications were excluded by physical 
examination, a white blood cell count, liver function tests and ultrasonography of the 
abdomen. Since all patients opted for laparoscopic operation, the kind of operation was 
performed according to availability of laparoscopic sets, thus avoiding patient selection. 
Laparoscopic cholecystectomy (LC): Fourteen patients, 1 male and 13 female, underwent 
laparoscopic cholecystectomy. Their mean age was 45 years (range 30-68). Median Quetelet-
index was 24.8 kg/m' (range 20.5-38.1). LC was performed via four abdominal incisions after 
insufflation of carbon dioxide. LC was performed under general anesthesia, as an inpatient 
procedure. Intra-operative cholangiography was not performed. 
Conventional cholecystectomy (CC): Seventeen patients, 3 male and 14 female, underwent 
conventional cholecystectomy. Mean age was 49 years (range 30-67). Median Quetelet-index 
was 24.5 kg/m' (range 19.5-38.1). CC was performed by laparotomy, via an oblique 
subcostal incision. It was performed under general anesthesia, as an inpatient procedure. Intra-
operative cholangiography was not performed. 
Follow-up: Follow-up consisted of self-administered health questionnaires, symptom profiles 
and pain diaries. A Dutch translation of the Nottingham Health Profile was used for the 
quality of life assessment [7]. This health profile questionnaire consists of 6 so-called 
domains, which are explored in 38 questions requiring a 'yes' or 'no' answer (dichotomous). 
The more questions answered with 'yes' and the higher the patient scores, the lower is the 
quality of life. 'Health gain' can be defined as, the decrease in median score (the median 
decrease in the number of positively answered questions). On the symptom profiles, the 
patients had to score whether they suffered from the following gastrointestinal complaints: 
nausea, fat intolerance, vomiting·, bloating, pyrosis, belching, constipation and diarrhoea.. 
Scoring was performed on a semi-quantative scale (absent, mild, moderate or severe). On the 
self-administered 'pain diaries', patients had to fill in the date, the duration and severity 
33 
(mild, moderate or severe) of pain, when experiencing pain. Patients experiencing pain had 
to indicate specifically whether this pain was similar or different from the pain they 
experienced before cholecystectomy. Health questionnaires and symptom profiles were taken 
before therapy (t=O) and at 3, 6, 12, 18 and 24 months after therapy. Pain diaries covered 
only the post-operative phase, i.e. 0-3, 3-6, 6-12 and 12-18 months. Health questionnaires, 
symptom profiles and pain diaries were sent by mail and double-checked by telephone I 
month after receipt. 
Statistics: Statistical analysis was done with the Kruskal-Wallis test, Wilcoxon rank test and 
a standard test for comparing proportions assuming binomial distributions. A p-value of 
<0.05 was considered statistically significant. 
RESULTS 
Lal'aroscopic cholecystectomy: Mean and median hospitalization time, including the days of 
admission and discharge, were 5 days (range: 4-9). No laparoscopic cholecystectomy was 
converted into conventional cholecystectomy. Postoperatively, no complications occurred and 
there was no mortality. Mean follow-up was 13.1 months (median: 12; range: 3-24). No 
patient was lost to follow-up. 
Conventional cholecystectomy: Mean and median hospitalization time, including the days of 
admission and discharge, were 9 days (range: 6-12). Postoperatively, one patient had to be 
observed for 6 hours at an intensive care unit for an epileptic insult. One patient suffered from 
wound dehiscence, treated conservatively. Two patients complained of persistent scar pain. 
There was no mortality. Mean foIlow-up was 23.6 months (median: 24; range: 18-24). No 
patient was lost to follow-up. 
Ouality of life: NHP-questionnaires were returned and filled in correctly in 96.5% (165/171) 
of the cases. It was found that the median overall percentage of items answered positively, 
decreased to the same degree in both treatment groups after operation (Figure I). This 
decrease, however, became significant 6 months after LC and only 12 months after CC. 
Health status remained significantly better thereafter in both groups (not shown). There was 
no significant difference at baseline between the two treatment groups. 
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Symotom profiles: The reported frequencies of nausea, fat intolerance and bloating in the 
courSe of I year, are depicted in Table I. Both fat intolerance and nausea improved 
significantly and consistently after 6 months in the LC-group but not in the CC-group. Here, 
a significant improvement in fat intolerance and nausea occurred only after 18 and 24 months, 
respectively (not shown). Bloating improved significantly after 3 and 6 months in the LC and 
CC-grouP. respectively_ Vomiting and belching improved only slightly in both treatment 
groups, but improvements were statistically insignificant. Reported. frequencies of pyrosis, 
constipation and diarrhoea did not change after therapy. There were no significant differences 
in reported symptoms between the two treatment arms at baseline. 
HEALTH GAIN AFTER CHOLECYSTECTOMY 
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Pain diaries: Post-cholecystectomy biliary pain was found in 5 patients in the CC-group (29%) 
and I patient (7%) in the LC-group. This difference is not statistically significant (p=O.12) 
In the CC-group, 4 patients complained of 2-4 and I patient of II pain episodes, respectively. 
The LC-patient reported only I episode. Pain episodes were considered mild, moderate or 
severe in 29, 48 and 24%, respectively. No biliary pain was reported in either group 6 
months after cholecystectomy. 
Table 1 
Reported frequencies (in %), graded moderate or severe, of fat intolerance~ nausea 
and bloating after laparoscopic (n:= 14) and conventional cholecystectomy (n= 17). 
Time Fat Nausea Bloating 
(mths) intolerance 
LC CC LC CC LC CC 
0 47 37 47 37 33 47 
3 33 21 8" 16 O' 32 
6 O' 33 O' 17 10 11" 
12 O' 16 O' 26 O' 11' 
LC: laparoscopic cholecystectomy; CC: conventional cholecystectomy 
a) p < 0.05; compared with 1=0 
b) p<0.02; compared with '~O 
36 
DISCUSSION 
Laparoscopic cholecystectomy has revolutionized surgical practice to a great extent and it has 
been claimed that it is the new gold standard for the treatment of symptomatic gallstone 
disease [8]. However, well-controlled studies are unavailable [5] and there is little or no 
prospect of a randomized study ever being performed [9]. 
The few available controlled studies all have some drawbacks. Firstly, they have all used 
historic controls [10-12]. Secondly, they focussed on complications and mortality [11,12]. 
Since both laparoscopic and conventional cholecystectomy were accompanied by relatively low 
morbidity and mortality rates, these rates were insensitive and, therefore, inappropriate for 
detecting differences between the two treatment arms in small series of patients [1,13,14]. 
Thirdly, they also focussed on operation time, length of hospital stay and use of analgetics 
[10], factors which were of only partial interest to the patient. 
We studied laparoscopic cholecystectomy prospectively in comparison to conventional 
cholecystectomy, which has been the standard operation for gallstone disease for more than 
a century [4]. We focussed on quality of life, because this would be of major interest to the 
patient. Moreover, minimally invasive surgery is an area particularly well suited for quality-
of-life research [14] and in fact, improving quality of life should always be the most important 
aim in the elective treatment of symptomatic gallstones [3]. No other reports on quality oflife 
after laparoscopic cholecystectomy are available. 
We chose the Nottingham Health Profile, since it is well validated and one of the most widely 
used general measures of quality oflife [13]. Moreover, it can be easily administered by mail 
and makes relatively small demands on patient time and effort [13-15]. Because there was a 
significant difference in the length offollow up between the two treatment groups (p=0.027). 
we only analyzed the data of the first year in the LC-group. 
We found that both operations were safe, relieving biliary colics and improving both quality 
of life and three gastrointestinal complaints, i.e. fat intolerance, nausea and bloating. We also 
found that other dyspeptic symptoms may persist after cholecystectomy, which is in agreement 
with the literature [16-19]. Because of the specific design of the pain diaries and symptom 
questionnaires, we were able to confirm that the reported symptoms were usually mild and 
of short duration [16-19]. We, therefore, confirmed that cholecystectomy is justified as a 
treatment of uncomplicated symptomatic gallstone disease. 
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In comparison with conventional cholecystectomy, we have demonstrated that laparoscopic 
cholecystectomy achieved an improved quality of life at a significantly earlier time. This was 
also the case with fat intolerance, nausea and bloating. The cause of the earlier disappearance 
of these dyspeptic symptoms after laparoscopic cholecystectomy remains unclear. Finally, we 
confirmed that laparoscopic cholecystectomy caused a marked reduction in the length of 
hospital stay. 
The drawbacks of our study were that it was not randomized and that the number of patients 
studied was relatively small. Our study could not be designed as a randomized study, because 
it was initiated in a phase where we did not constantly have a laparoscopic set at our disposal. 
Consequently laparoscopy could not be planned and in fact it was unpredictable what 
treatment hospitalized patients would get. Also, we doubt whether randomization would have 
been possible: when laparoscopic sets were constantly available, patients simply refused 
random assignment of treatment and chose laparoscopic cholecystectomy. Despite of these 
defects, the present study was prospective, controlled and had a relatively long follow up. We 
have, therefore, provided more circumstantial evidence that laparoscopic cholecystectomy is 
superior to conventional cholecystectomy. 
SUMMARY 
We prospectively studied the course of quality of life and gastrointestinal and biliary 
complaints after laparoscopic and conventional cholecystectomy. It was found that 
cholecystectomy improves quality of life and cures fat intolerance, nausea, bloating and biliary 
pain. It was also found that laparoscopic cholecystectomy improved quality of life and 
symptomatology at an earlier stage than conventional cholecystectomy. More circumstantial 
evidence is provided that laparoscopic cholecystectomy is superior to conventional 
cholecystectomy. 
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ABSTRACT 
Objective: comparison of the results of laparoscopic and conventional cholecystectomy. 
Design: matched clinical study. 
Setting: department of Surgery, University Hospital Rotterdam, Rotterdam, The Netherlands. 
Subjects/interventions: the first 100 -unse1ected- patients with a 1aparoscopic cholecystectomy 
(median age 46 years, [21-78]), operated on in the period September 1990 to October 1992 
were matched with patients who had undergone open cholecystectomy (median age 45 years, 
[21-82]) in the period August 1988 to August 1991. 
Main outcome measures: conversion, complications of both techniques. 
Results: patients with acute cholecystitis or a chronically inflamed gallbladder had an 
increased risk of conversion (50%). Also older patients had an increased risk (23%). There 
was no mortality in both groups. Major, minor and late complications of laparoscopic 
cholecystectomy occurred in 5, 6 and 3 %, respectively. For open cholecystectomy these rates 
were 3,6, and 3%, respectively. 
Conclusion: Both techniques are safe, but the complications of the 1aparoscopic 
cholecystectomy were more serious. Careful evaluation of this technique, preferably in the 
form of a randomised trial, is still necessary. 
INTRODUCTION 
Gallstone disease is an important clinical problem with great economical concequences 
(14,23,28,29). Gallstones become symptomatic in about 10-15% of the patients and only then 
require treatment (8,24,26,32). Since the first successful gallbladder resection in 1882 (15), 
cholecystectomy is considered the therapy of choice for symptomatic cholecysto1ithiasis (16). 
Cholecystectomy is considered curative and is accompanied by a morbidity of 10-30% and 
a mortality of 0.1-0.6% (13,16,17). The first series of laparoscopic cholecystectomies was 
reported in 1990 (7). Laparoscopic cholecystectomy is a variant of open cholecystectomy but 
major advantages of this technique are a markedly diminished need for postoperative narcotic 
analgesics, early discharge from the hospital and a quicker return to work (4,30,31). The 
cosmetic result is experienced as another advantage. Contraindications for a laparoscopic 
cholecystectomy are sepsis, peritonitis, distended bowels and pregnancy (10). However, 
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recently successfullaparoscopic cholecystectomy has been described in the first 2 trimesters 
of pregnancy (II). Relative contraindications are previous upper abdominal surgery, acute 
cholecystitis and a chronically inflamed gallbladder; they form the main causes of conversion 
to open cholecystectomy in about 5-10% of the cases (2,12,31). The most severe complication 
of laparoscopic cholecystectomy is bile duct injury. This is mostly due to ntisidentifying the 
common bile duct for the cystic duct, a short cystic duct or inaccurate placement of clips. The 
reported higher incidence of bile duct injury compared to open cholecystectomy gives rise to 
concern (5,18,22,31). 
A proper comparison between open and laparoscopic cholecystectomy could only be achieved 
in the context of a randomised controlled trial. However, after the rapid introduction of 
laparoscopic cholecystectomy, what is said to be partly consumer driven (3), very few 
controlled studies have been performed (30). 
Since the advantages of laparoscopic cholecystectomy are obvious and the procedure has 
gained its place in routine surgical practice, a randomised trial will probably never be 
conducted (19). Therefore, the first 100 cases oflaparoscopic cholecystectomy performed in 
our hospital were compared with 100 matched patients who had undergone an open 
cholecystectomy in the period preceding the introduction of the laparoscopic cholecystectomy. 
PATIENTS AND METHODS 
From September 1990 to October 1992,100 unselected patients with symptomatic gallbladder 
stones underwent laparoscopic cholecystectomy. To compare the results of this operation with 
open cholecystectomy, the patients were matched for sex, age, ethnic group and ASA-
classification (anaesthetic risk, [20]) with patients who had had an open cholecystectomy 
during the period August 1988 to August 1991. In the period between September 1990 and 
August 1991, both open and laparoscopic cholecystectonties were performed. Patients were 
operated laparoscopically iflaparoscopic equipment was available and if not, they had an open 
cholecystectomy. Therefore, the nature of the operation only depended on the place on the 
waiting list, thus avoiding selectivity. After August 1991, all cholecystectomies were 
performed laparoscopically because of the continuous availability of laparoscopic sets. 
Patients, who underwent cholecystectomy in combination with a common bile duct exploration 
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were excluded from the study since this procedure is not yet performed laparoscopically in 
our hospital. Finally, a IS-year old patient in the laparoscopic group was excluded from the 
study because she could not be age-matched. This patient underwent an uncomplicated 
laparoscopic cholecystectomy. 
Table I shows the characteristics of both groups. 
Table I 
Characteristics of 2 groups of patients operated by either laparoscopic or open cholecystectomy. 
# (m/f) 
Median age (range) 
Ethnic minority 
ASA-class I-II 
ASA-class Ill-IV 
Laparoscopic 
cholecystectomy 
100 (27/73) 
46 (21-78) 
n=29 
n=94 
n=6 
Open 
cholecystectomy 
100 (25175) 
45 (21-82) 
n=29 
n=95 
n=5 
#: number of patients; m: male; f: female; ASA-class: ASA-classification (29) 
One female patient treated by laparoscopic Cholecystectomy underwent laparoscopic 
sterilization' in the same session without complications. 
Laparoscopically operated patients were followed prospectively, patients who had an open 
cholecystectomy retrospectively. 
In the laparoscopic group the presence of relative contraindications for laparoscopic 
cholecystectomy was assessed preoperatively. Suspicion of concontitant common bile duct 
stones was not regarded as a relative contraindication but resolved preoperatively by 
endoscopic treatment. All complications, conversion to open cholecystectomy and the duration 
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of the operation were recorded. The total number of hospitalization days was counted, starting 
from the day of operation and including days of readmittance. At follow-up, patients were 
asked about postoperative pain, biliary symptoms and gastrointestinal complaints. 
In the open cholecystectomy group, all complications, duration of the operation and the 
number of hospitalization days were recorded. 
In comparing the complications of the laparoscopic and open cholecystectomy, a conversion 
from the laparoscopic to the open technique in itself was not considered a complication but, 
of course, could be the consequence of a complication. 
Statistical analysis was performed using a standard test for comparing proportions assuming 
binomial distributions. 
RESULTS 
Duration of the operation and of the hospital stay are depicted in Table 2, comparing the open 
with the laparoscopic technique. 
Table 2 
Operation time and hospitalization. 
Median duration 
operation 
(hours) 
Median duration 
hospitalization 
(days) 
Open cholecystectomy 
1.0 (0.5-2.8) 
7 (4-38) 
45 
Laparoscopic cholecystectomy 
1.5 (0.8-4.3) 
converted: 2 (1.3-3.3) 
not converted: 1.5 (0.8-4.3) 
4 (1-140) 
converted: 7 (4-140) 
not converted: 4 (1-36) 
Conversion 
Thirteen patients had a conversion to open cholecystectomy (overall conversion rate: 13%). 
Of the first 25 patients, four were converted. Of the next three groups of 25 patients, five, 
one and three were converted, respectively. Four out of seven patients with clinical and 
ultrasonographic signs of acute cholecystitis were converted. In another seven patients, an 
inflamed gallbladder was found at preoperative ultrasound. Three of these patients were 
converted. Two conversions were due to adhesions, causing insufficient abdominal distension 
(one patient) and restricted view (one patient). Finally, four conversions followed an 
intraoperative complication. Thus, the conversion rate for 14 patients with relative 
contraindications for laparoscopic cholecystectomy was 50% (7114) and for 86 patients 
without relative contraindications 7,0% (6/86, p<O.OOI; two sample proportion test). 
Age was found to be a risk factor for conversion. Ten of the 44 patients aged 50 years and 
older (23 %) had a conversion, whereas three of the 56 patients aged 49 years and younger 
(5.4%) had a conversion (p= 0.01; two sample proportion test). 
There were no conversions due to the presence of common bile duct stones. In six patients 
concomitant common bile duct stones were suspected: in three, a preoperative endoscopic 
sphincterotomy and stone extraction cleared the common bile duct. In the other three patients, 
nortnalization of liver function tests before the operation led to the diagnosis of spontaneous 
passage of common bile duct stones. Intraoperative cholangiography, performed in one of 
them, did not show any abnortnalities. 
Complications (Table 3) 
There was no mortality in both groups. 
Laparoscopic cholecystectomy: Fourteen complications occurred in 12 patients. There were 
five major complications: one patient had a perforation of the cecum at trocar introduction, 
necessitating conversion. three patients had a laparotomy after signs of postoperative bile 
peritonitis. Two of them had bile duct lesions -I at the confluence of the cystic duct and the 
other of the common bile duct- which were repaired. The third patient had a clip 
dislodgement, what could be managed by ligation of the cystic duct. In one patient with acute 
cholecystitis, a -presumably infected- stone was lost in the abdominal cavity. He developed 
a bacterial peritonitis and an infected hematoma, for which laparotomy was necessary. There 
were six minor complications: intraoperative bleeding occurred in three patients (one 
46 
mesenterial vein bleeding and two bleedings from the gallbladder bed due to minor ruptures 
of liver tissue) which was stopped after conversion. In two patients, wound infection occurred 
at the site of introduction of a trocar and in one patient, a cystic duct leak was managed by 
endoscopic drainage. Three patients were readmitted for repair of an incisional hernia: two 
after a converted laparoscopic cholecystectomy and one after a laparoscopic cholecystectomy. 
Open cholecystectomy: Twelve complications occurred in 11 patients. Three patients had 
major complications: one had a lesion of the duodenum, needing intraoperative repair. One 
patient had a relaparotomy for postoperative bleeding and one patient needed prolonged 
drainage (29 days) for a subphrenic abeess. No bile duct lesions occurred. Six minor 
complications (Table 3) were managed conservatively. Three patients were readmitted, one 
for repair of an incisional hernia and two for unsuspected retained common bile duct stones, 
that could be successfully treated by an endoscopic sphincterotomy. 
Follow-up 
Ninety four patients in the laparoscopic group were seen 10-14 days after discharge from the 
hospital. Thirteen of them (14%) complained of wound pain; six of those had been converted. 
The other seven patients reported only moderate pain at the sites of introduction of the 
trocars. Eight patients (9%) had an elevated serum alkaline phosphatase level (up to twice 
reference values) what declined after two more weeks in five patients. In the other three 
patients it remained elevated without other signs of biliary ductal obstruction. This was 
probably related to medication taken for concomitant diseases because it was already present 
preoperatively. One patient reported a one day-period offever up to 39 degrees which did not 
recur. Another patient twice observed pale coloured stools which did not recur. 
All patients reported to have resumed daily activities. No gastrointestinal complaints of 
importance were reported. 
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Table 3 
Complications in 100 laparoscopic cholecystectomies and in 100 open cholecystectomies. 
Laparoscopic 
cholecystectomy 
Major (n=5) 
Cecal perforation 
Bile leak 
Common bile duct 
Cystic/common bile duct 
Cystic duct 
Infected stone in abdomen 
Minor (n=6) 
Intraoperative bleeding 
Mesenterial (I) 
Gallbladder bed (2) 
Cystic duct leak 
Wound infection (2) 
Late (n=3) 
Incisional hernia 
Converted patients (2) 
Not converted patient (I) 
Total: 14 
n: number of patients 
DISCUSSION 
Open 
cholecystectomy 
Major (n=3) 
Duodenal laceration 
Postoperative bleeding 
Subfrenic abcess 
Minor (n=6) 
Mild decrease hemoglobin level 
Postoperative fever (2) 
Wound infection (3) 
Late (n=3) 
Incisional hernia 
Retained common bile duct stones (2) 
Total: 12 
For more than a century, cholecystectomy by laparotomy has been the treatment of choice in 
case of symptomatic cholecystolithiasis for two basic reasons. In the first place 
cholecystectomy can be performed in almost any patient and secondly there is no possibility 
of stone recurrence. Laparoscopic cholecystectomy has proved to have important advantages 
over the open technique (4,30,31). However, critical evaluation of morbidity and mortality 
of this technique are necessary and especially data on the incidence of bile duct lesions are 
important (5,18,22,31). 
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Almost all studies of laparoscopic cholecystectomy are descriptive (2,4,7,10-12,22,31) and 
controlled studies only comprise limited numbers of patients (30). Therefore we decided to 
compare the first 100 laparoscopically cholecystectomized patients with 100 conventionally 
treated patients. The patients were only selected for the presence of symptomatic 
cholecystolithiasis and were adequately matched (Table 1). 
In the laparoscopic group, the conversion rate was 13 %. In the presence of acute cholecystitis 
or a chronically inflamed gallbladder, the conversion rate was 50%, whereas if these patients 
were excluded, this rate would have been 7.0%. a significant difference. This finding is in 
accordance with other studies, reporting conversion rates of 33-60% in cases of acute 
cholecystitis (9,12). Older patients had a significantly increased risk of conversion (23%), 
largely due to a high rate of acute cholecystitis and chronically inflamed gallbladders in this 
group. As a consequence, patients with relative contraindications should have the increased 
risk of conversion pointed out clearly to avoid raising expectations of minimal hospital stay 
and early return to daily activities. 
Mortality in both groups was zero, and this confirms the relative safety of both techniques. 
Morbidity of the open cholecystectomy was consistent with other series (13,16,17). When 
comparing both groups, morbidity was more serious in the laparoscopic group (Table 3): four 
patients had to be reoperated for various reasons, whereas in the open cholecystectomy group, 
this was the case in only one patient. In the laparoscopic group, two -minor- bile duct lesions 
had to be repaired; bile duct lesions did not occur in the open cholecystectomy group. 
We also wish to draw attention to the possibility of spilling infected bile and stones into the 
abdomen: when removing the gallbladder laparoscopically, it is more likely to rupture than 
during the open technique. This spill may cause intra-abdominal infections: a reason for being 
careful in performing a laparoscopic cholecystectomy in patients after acute cholecystitis 
which should therefore be done under antibiotic cover. 
A learning curve in the laparoscopic technique could not be demonstrated in this series: in the 
first group of 25 patients four being converted; in the next three groups of 25 patients five, 
one, and three being converted respectively. Also, the number of complications did not 
decline as the number of laparoscopically operated patients increased. The two bile duct 
lesions and cecal perforation occurred in the last 25 patients. This is in accordance with the 
observation in open cholecystectomy, where most complications occur after the operator has 
performed the first 25 operations (I). Furthermore, it is likely that in a teaching hospital a 
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learning curve will emerge later because of the considerable number of surgical trainees 
specializing in biliary surgery. 
Although laparoscopic cholecystectomy is now claimed to be the treatment of choice (27), our 
approach towards this new and rapidly introduced technique should be cautious, especially in 
an unselected, symptomatic population. Many reports oflaparoscopic cholecystectomy are the 
work of expert biliary surgeons (2,4,7,10-12,21,25,27,30,31). Consequently, it can be 
expected, that complication rates will be higher in less expert hands. A large survey of 4,292 
hospitals and 77,604 cases of laparoscopic cholecystectomy demonstrated a mean rate of bile 
duct injury of 0.6% and significant complications were identified in 2 % (6). It was stated, that 
patient selection was an important factor. 
We conclude, that the complications of laparoscopic cholecystectomy may still be 
underestimated. Despite its apparent advantages, comparison with the open technique in a 
randomised clinical trial is still warranted. 
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ABSTRACT 
Routine surgical bile duct exploration and extraction of stones is no longer available during 
a laparoscopic cholecystectomy, unless conversion to open operation is undertaken. The 
consequences of this phenomenon are therefore to manage suspected bile duct stones 
preoperatively and unsuspected retained stones postoperatively. Through a review of the 
literature combined with our experience with extracorporeal shock wave lithotripsy (ESWL) 
we conclude that endoscopic sphincterotomy (ES) and ESWL together can achieve stone 
clearance in 97-99% of all patients with choledocholithiasis. Routine intraoperative 
cholangiography during laparoscopic cholecystectomy can be replaced by a selective 
preoperative endoscopic retrograde cholangiography, followed by ES if necessary. 
Unsuspected retained stones can be treated with postoperative ES and ESWL. 
INTRODUCTION 
It is generally agreed that only patients with symptomatic cholecystolithiasis require therapy 
(1-3). Most patients remain asymptomatic, but 10-15% develop biliary colics (4). Stones in 
the common bile duct are sometimes the reason for these colics. About 9-16 % of the patients 
with symptomatic cholecystolithiasis also have choledocholithiasis (5,6). 
The management of patients with cholecystolithiasis and possible choledocholithiasis has been 
discussed extensively in the literature. Since the introduction of the laparoscopic 
Cholecystectomy routine surgical bile duct exploration and extraction of stones is no longer 
available, unless conversion to open operation is undertaken. To develop an adequate strategy 
for this problem, we reviewed the literature and incorporated our results of extracorporeal 
shock wave lithotripsy (ESWL) of common bile duct stones. 
In jaundiced patients with upper abdominal pain, fever and documented cholecystolithiasis the 
probability of concomitant choledocholithiasis is as high as 36-60% (7,8). Biochemical 
variables (elevated liver function test results) can add to this suspicion (7-9). A combination 
of these variables increases the probability of choledocholithiasis to more than 90% (8). 
Finally, various imaging techniques can be used to complete the investigations for 
choledocholithiasis. Ultrasonography can demonstrate common bile duct dilatation and, less 
frequently, the presence of stones. The probability of choledocholithiasis increases with the 
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diameter of the common bile duct: more than 34% if the diameter exceeds 10mm and more 
than 80% if it exceeds 12mm (7,8), A combination of positive clinical, biochemical and 
imaging indicators makes the diagnosis choledocholithiasis almost certain (8), Intravenous 
cholangiography (IYC) for the detection of common bile duct stones has been abandoned 
almost entirely. Recent reports, however, suggest there still may be a role for lye: new 
contrast agents are claimed to be safer and hypo-allergic at the correct infusion rate (10), 
Results of routine IYC are reported to equal those of routine intraoperative cholangiography 
(IOC)(1l-14), IOC during an open cholecystectomy is a sensitive method for detecting 
common bile duct stones with a positive predictive value of about 60-90% and a negative 
predictive value of almost 100% (15), There has been much discussion whether to use JOC 
routinely (16-21) or selectively (15,22-26), Detection of common bile duct stones with JOC 
will almost invariably lead to a choledochotomy and common bile duct exploration (CBDE) 
to extract the stones, Surgical CBDE is an accepted therapy but is associated with an 
appreciable mortality, rising to 8% in elderly or high-risk patients (27-30), This mortality rate 
is even higher in emergency procedures regardless of age (31). It is known that the population 
with cholecystolithiasis and concomitant choledocholithiasis is significantly older than the 
population with only cholecystolithiasis (7,8,32-34), Since the introduction of endoscopic 
retrograde cholangiography (ERC) combined with endoscopic sphincterotomy (ES)(35,36), 
this has become the treatment of choice for choledocholithiasis in elderly and high-risk 
patients (37-41), Morbidity from ES (pancreatitis, cholangitis, bleeding and retroperitoneal 
perforation) is reported to be 5-15% versus 15-30% after CBDE (27,37,41-44). Mortality 
from ES is about 1-2% (37,41,42,44) and does not increase with age and the presence of 
medical risk factors (43) in contrast to mortality after a CBDE (27-30). In selected patients 
with a high operative risk, the gallbladder can be left in situ after ES (43,45-48). 
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PROBLEMS 
Nowadays, laparoscopic cholecystectomy has become the routine treatment modality for 
patients with symptomatic cholecystolithiasis. Here, too, there is much debate on whether to 
use IOC routinely (49-51) or selectively (52,53). However, the consequences of a positive 
IOC have changed in case of laparoscopic cholecystectomy: a conversion to laparotomy is 
needed for a CBDE to remove the stones. Not only will this increase morbidity and mortality, 
but also the advantages of a laparoscopic cholecystectomy (diminished need for narcotic 
analgesics, early discharge from the hospital, quicker return to work (54-56)) will be lost. 
False positive IOC occur in from 8% up to more than 30% of the cases (15,16,19,32,38,57-
59), leading to unnecessary CBDE and, in case of laparoscopic cholecystectomy to 
unnecessary conversion and CBDE. In addition, bile duct injury during open cholecystectomy 
can be caused simply by placement of cholangiographic cannula (60,61), and there is no 
reason to believe that this would not occur during laparoscopic cholecystectomy. 
To preserve the minimal invasive character of the laparoscopic cholecystectomy, it would be 
simpler to anticipate and focus on indicators of choledocholithiasis in the preoperative period. 
A preoperative ERC can be performed on the basis of these indicators and an ES to remove 
any common bile duct stones. Therefore, it is important to define a subset of clinical, 
biochemical, and radiological parameters which can predict choledocholithiasis with a 
reasonable probability. 
The age limit for ES must also be defined because of its potential long-term complications, 
such as stenosis of the sphincterotomy or reflux of air and intestinal contents into the biliary 
tree and subsequent bacterial overgrowth (62). For these reasons, to date, ES has been largely 
confined to patients with an age-limit of about 50-60 years (63,64). However, if the above-
mentioned objections should prove to be invalid, it would be unreasonable to deny a 
preoperative ES in combination with a laparoscopic cholecystectomy to the younger patient 
with choledocholithiasis in favour of a laparotomy with at least a considerably longer hospital 
stay and higher morbidity. 
An important remaining problem is that endoscopic extraction of common bile duct stones 
proves impossible in about 10% of the cases (37,44,45,65). Common bile duct stones with 
a diameter exceeding 20 mm are increasingly difficult to remove, even with a balloon or a 
Dormia basket (66). 
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Finally, there will always be a rate of 2-8% of unsuspected choledocholithiasis (32,67-71). 
If the routine use of IOC were to be abandoned, these stones would be missed, which could 
eventually lead to symptoms after the laparoscopic cholecystectomy. 
POssmLE SOLUTIONS 
Table I summarizes the factors indicative of choledocholithiasis. All these indicators can 
predict choledocholithiasis with a probability of more than 34 % (7-9), which should give 
enough reason to perform a preoperative ERC and, if necessary, ES. Combinations of these 
indicators increase the probability up to 100% (8). 
Serum transaminases are of less importance in predicting choledocholithiasis (8,72), and, 
although pancreatitis has an aetiologic relationship with biliary tract stone disease, pancreatitis 
in itself or an elevated serum amylase is of little value as a predictor of choledocholithiasis 
(7-9,33,73). 
Table I 
indicators for common bile duct stones. 
Indicators 
Jaundice, light feces, dark urine 
Septic fever, cholangitis 
Bilirubin and alkaline phosphatase> twice elevated 
Diameter of .common bile duct> 10 mm on ultrasound 
Stone visible in common bile duct on ultrasound 
any combination of the above mentioned indicators 
PPY: positive predictive value (7-9); >: more than. 
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PPY 
>44% 
>36% 
>40% 
>34% 
>85% 
>90% 
In our view the age limit for ES can be less than 50 years. The long-term effects of ES are 
still unknown but seem to be better than expected. The rate of stenosis of the papilla after ES 
for choledocholithiasis is about 0-1 % after 1-2 years and 2-4% after 5 years (63,74-77). 
Retained or recurrent stones are found in about 6% after 5 years (63,77). This will be a good 
end-estimate because stone recurrence most probably occurs within 3 years after ES (78). In 
patients treated with a surgical sphincterotomy comparable to ES, a follow-up of 20-25 years 
has been achieved (79). Although this study only comprised 43 patients, none of them had 
experienced negative side-effects at follow-up. 
Recurrent biliary problems also occur after CBDE: the majority of benign biliary strictures 
are iatrogenic and due to previous cholecystectomy combined with CBDE and T-tube drainage 
in 9-32% of the cases (80-83). Retained or recurrent stones occur in about 5% of the cases 
after CBDE (27,38,84-86), which is comparable with ES. 
In case of failure of endoscopic extraction of bile duct stones, ESWL is an attractive 
alternative: in 70-88 % of these patients clearance of the common bile duct still can be 
achieved (87-92). In the period between April 1986 and July 1992 we treated 90 patients (33 
men, 57 women, median age 73 years, range: 27-95) with difficult common bile duct stones 
(median diameter: 25 mm) with ESWL. Sixty-two patients (69%) became free of stones. Six 
patients (7%) had an endoprosthesis placed past fragmented stones and 22 patients (24%) 
finally underwent an operation (93). 
Because of the low morbidity and mortality rates, we strongly argue also to treat patients 
younger than 50 years with ESWL. Only in case of failure of ESWL can a CBDE or bilio-
intestinal anastomosis be undertaken, and in the unfit patient an endoprosthesis can be placed 
past the common bile duct stones to ensure biliary drainage. 
Finally, it is estimated that only 10% of patients with unsuspected choledocholithiasis become 
symptomatic (15). So, 90% of the patients undergoing laparoscopic cholecystectomy probably 
will not benefit from an IOC-indicated conversion and CBDE and only have the risk of the 
additional morbidity and mortality. Prospective randontised trials, in both open and 
laparoscopic cholecystectomy, do not show advantages of routine IOC in detecting 
unsuspected common bile duct stones (94,95). Emphasis must be put on preoperative clinical 
criteria. Any unsuspected stones, causing symptoms after laparoscopic cholecystectomy, can 
be treated with ES (53,96), after which a reoperation seldom will be necessary (38). This will 
especially be the case if ESWL is added to the therapeutic regimen. 
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DISCUSSION 
To achieve a reliable treatment strategy concerning the possibility of choledocholithiasis in 
patients undergoing laparoscopic cholecystectomy, we reviewed the literature and considered 
our results of ESWL of common bile duct stones. We shall not discuss definite emergency 
situations in which endoscopy has the advantage over emergency surgery, namely acute severe 
cholangitis and acute severe pancreatitis associated with bile duct stones. 
Since 1aparoscopic cholecystectomy is the new standard treatment of cholecystolithiasis (97), 
surgical CBDE and stone extraction is no longer available, unless conversion to open 
operation is undertaken. Laparoscopic exploration of the bile ducts has already been described 
(98,99) but is not yet generally feasible. 
Routine laparoscopic IOC can be replaced by selective preoperative ERC, based on clinical 
presentation, laboratory evaluation and ultrasonography (Table 1)(53,95,96,100, 101). 
However, in selected cases IOC retains a role as a road map for the laparoscopic surgeon. 
Patients aged 40 years and older can have a preoperative ES. It remains questionable whether 
this would be wise in patients younger than 40 years, who only rarely harbour common bile 
duct stones. In case of difficult common bile duct stones, ES can be combined with ESWL 
as a non-invasive, effective treatment modality with very low morbidity and mortality rates. 
ESWL treatment can clear the common bile duct of difficult stones in up to 88 % of the cases 
(91), which means that ES and ESWL together can achieve stone clearance in 97-99% of all 
patients with choledocholithiasis. In fact, this would be a better clearance rate than after a 
CBDE, for which it is about 95% (27,38,84-86). Morbidity from ESWL of common bile duct 
stones is low: transient macrohematuria occurs in 2-11 % of the patients and transient 
hemobilia in 2-8% (87,88,91,93). Septic fever in 3-6% of the cases is often regarded as an 
exacerbation of already existing cholangitis (87-89,92,93). To the best of our knowledge, 
death from ESWL has not been reported to date. Unsuspected stones are estimated to cause 
symptoms in only 10 % of the cases (15). In case of symptoms a postoperative ES must be 
attempted, when necessary in combination with ES\VL. 
Further development of new techniques has led to the recent use of endoscopic ultrasound of 
the bile ducts. This method is not only valuable for detection and staging of tumours of the 
common bile duct (102) but also accurate in diagnosing stones in the common bile duct (103). 
Another promising technique for the treatment of common bile duct stones is endoscopic or 
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percutaneous laser lithotripsy under direct visual control (104). Further improvements of these 
methods can be expected, and they probably will become a valuable supplement in the 
diagnosis and non-surgical treatment of common bile duct stones. 
We conclude that ES and ESWL together can achieve stone clearance in 97-99% of all 
patients with choledocholithiasis and is therefore the preferred treatment strategy as the first 
step in symptomatic patients before laparoscopic cholecystectomy. Thus, conversion to 
laparotomy and CBDE can be avoided in almost all cases. This implies that these patients 
should be treated in centres where both ERC and ESWL are available. In an increasing 
number of these centers endoscopic ultrasound and lithotripsy will also be available. 
There will always be some cases in which indicators of choledocholithiasis are doubtful or 
marginally present. Here, the role of IVC should be reconsidered (11-14). 
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ABSTRACT 
To study the efficacy of extracorporeal shock wave lithotripsy (ESWL) of pancreatic duct 
stones, seventeen patients (mean age: 42 years) with recurrent attacks of abdominal pain as 
a result of chronic calcifying pancreatitis, were treated with this method. In all cases, 
endoscopic removal of the stones proved impossible. In case of fragmentation the remaining 
calculi and fragments either evacuated spontaneously or attempts were made to extract them 
endoscopically followed by flushing. In 13 patients (76%) fragmentation of stones was 
achieved, Il of which had a dramatic relief of pain directly after ESWL (65%). However, 
in only 7 patients (41 %) complete ductal clearance of stones was achieved; at last follow-up 
(12-59 months after ESWL, mean: 30 months) all 7 were free of symptoms. Of the 6 patients 
with stone fragmentation without ductal clearance, 3 were operated on because of recurrent 
complaints. The only complication due of the procedure was an exacerbation of pancreatitis 
in I patient, which could be treated conservatively. If pancreatic stones cannot be removed 
endoscopically, ESWL seems to be preferable to surgery which may be performed in case 
of failure. It seems important to achieve ductal clearance and not merely stone disintegration 
to obtain the desired clinical long-term effects. 
INTRODUCTION 
Treatment of chronic calcifying pancreatitis (CCP) is a difficult clinical problem, for which 
extensive surgery has often to be performed (1-3). Alcohol abuse is considered to be the main 
cause of CCP (3,4) and up to 90% of the patients with alcoholic chronic pancreatitis develop 
stones in the main pancreatic duct (4). The course of this disease can eventually result in 
endocrine as well as exocrine insufficiency of the pancreas, leading to insulin dependent 
diabetes mellitus and steatorrhea and creatorrhea, respectively. 
The treatment of CCP should be focussed on pain relief, management of biliary obstruction 
and drainage of pancreatic pseudocysts (5). If stones are present in the main pancreatic duct, 
the treatment of choice is nowadays sphincterotomy of the pancreatic orifice followed by 
endoscopic stone extraction or placement of an endoprosthesis in the main pancreatic duct 
(6,7). However, endoscopic stone extraction is sometimes impossible because ofa discrepancy 
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between the diameter of the stones and the diameter of the distal pancreatic duct and due to 
ductal strictures as a result of fibrosis of pancreatic tissue (1). Furthermore, previous upper 
abdominal surgery can make endoscopic access to the pancreatic orifice impossible. After 
failure of endoscopic measures, these patients are usually treated surgically (side-to-side 
pancreato- jejunostomy, partial pancreatic resection, main pancreatic resection). Pancreatic 
surgery, however, is accompanied by a considerable morbidity and mortality of 20-40% and 
2-5% respectively (8,9). 
The first case of ESWL of pancreatic stones was described in 1987 (10). Encouraged by this 
and our first results of ESWL of common bile duct stones (11), we wanted to know whether 
this non-invasive treatment method could be an alternative to pancreatic surgery in selected 
cases. We present the results of our first 17 patients with pancreatic stones treated by ESWL 
associated with therapeutic endoscopy in our institution. 
PATIENTS & METHODS 
From June 1988 until February 1992 we applied ESWL to 17 patients (10 male, 7 female; 
mean age: 42 years, range: 19-55 years) with pancreatic stones. The characteristics of these 
patients are shown in Table 1. 
The diagnosis 'chronic pancreatitis' was based on patients' history (chronic upper abdontinal 
pain or recurrent attacks of upper abdominal pain), the presence of calcifications in the 
pancreatic region on a plain abdominal roentgenography and the radiological aspect of chronic 
pancreatitis on endoscopic retrograde cholangio-pancreaticography (ERCP)(12). Two patients 
(3 and 14) had a common bile duct stenosis that complicated the course of their disease. This 
could be treated successfully by placement of an endoprosthesis in the common bile duct. 
ESWL was performed by a physician using a second generation lithotriptor, the Siemens 
Lithostar", (Siemens, Erlangen, Germany) which operates on an electromagnetical shock wave 
generation principle (13). In every case endoscopic pancreatic sphincterotomy and stone 
extraction had been attempted first, but failed because of a discrepancy between the diameter 
of the stone and the diameter of the distal pancreatic duct. 
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Table 1 
Patient and treatment characteristics of 17 patients with chronic calcifying pancreatitis. 
Patient mlf age # of Diameter Alcohol # of total #Duration 
(years) stones largest abuse sessions shock follow-up 
stone(mm) waves (months) 
I ~ 55 30 yes 2 10000 59 
2 ~ 47 2 15 no 2 6000 54 
3 a 41 2 30 yes 1 3000 52 
4 a 44 I 12 yes 2 8000 50 
5 ~ 37 4 25 yes 1 1500 48 
6 ~ 22 2 20 no 1 8000 44 
7 a 48 1 16 yes 2 10000 44 
8 ~ 43 4 18 no 3 11000 34 
9 a 44 >4 20 yes 3 11000 30 
IO a 44 I 22 yes 2 8000 27 
11 ~ 54 1 40 ? 2 8000 26 
12 a 38 1 20 yes 2 12000 19 
13 ~ 19 > 10 14 no 4 23000 18 
14 a 45 >4 18 yes I 6000 18 
IS a 42 3 17 yes I 4000 14 
16 a 55 4 15 no 2 11000 14 
I7 a 31 8 22 no 2 10000 12 
m/f: male(o) or female(~); #: number. 
Before ESWL the following investigations were performed: a plain abdominal 
roentgenography, an ERCP, a coagulation profile, white blood cell count, hemoglobin, serum 
levels of amylase, total bilirubin, and liver enzymes (alkaline phosphatase, aspartate 
aminotransferase, alanine aminotransferase and gamma-glutamyl-transpeptidase). We made 
sure patients had no acute pancreatitis, acute cholecystitis,. cholangitis or concomitant common 
bile duct stones at the time of ESWL. All patients were treated in prone position under 24-h 
antibiotic prophylaxis (amoxicillin/clavulate, 1000/200 mg intravenously half an hour before 
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the treatment and 8 and 16 hours after the treatment). In IS patients stones could be visualized 
by fluoroscopy without contrast medium (Figure la). In 2 patients (13 and IS) the stones had 
such a low grade of calcification, that it was necessary to inject contrast medium via a naso-
pancreatic drain that was placed before ESWL. In the presence of 2 or more stones. the shock 
waves were focussed on the stone thought to cause the obstruction, usually the stone situated 
most distally in the pancreatic duct. If the vertebral column was in the shock wave path, the 
patients' right hip was slightly elevated to avoid exposure of vertebrae to shock wave energy. 
One patient was treated under general anesthesia on his own request, IS patients had 
intravenous analgo-sedation (fentanyl up to 0.1 mg and midazolam up to 5 mg intravenously) 
and 1 patient needed no analgesia at all. The shock waves were delivered at a mean energy 
level of 18,5 kV (range 16.2-19.0 kV). 
The day after ESWL a plain abdominal roentgenography was made and serum total bilirubin. 
amylase and liver enzymes were determined. The 2 patients with non-calcified stones were 
evaluated with repeat pancreatogram. If no stone fragmentation was seen on the abdominal 
X-ray, a second or third ESWL session was performed. If stone fragmentation was seen (clear 
change of contour of stone [Figure Ib]), a new attempt to extract the fragments endoscopically 
was made, after which a naso-pancreatic drain was left in place. Via this drain the pancreatic 
duct was flushed with 2 liters saline per 24 hours, which was tolerated well in all patients. 
If no stone material was detected following ESWL, flushing of the pancreatic duct was 
omitted and spontaneous clearance of the duct was assumed. If stone fragmentation did not 
occur after repeated ESWL and endoscopic sessions, surgery was recommended to the patient. 
Statistical evaluation was performed by the Wilcoxon test for matched pairs. 
RESULTS 
Short term results 
Of all 17 patients, treatment characteristics are shown in Table I; results are shown in Table 
2. 
Stone fragmentation: Thirteen patients (76%) showed radiologically proven stone fragmenta-
tion. Four patients (24 %) had no stone fragmentation, although in one (patient 5) treatment 
was ended prematurely (after 1500 shocks) because it was too painfull. Of the patients without 
stone fragmentation, 3 underwent a side-to-side pancreato-jejunostomy during the same 
admission. 
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Figure la 
Plain abdominal film showing a large calculus in the pancreatic region; confirmed by ERCP. 
Figure Ib 
Plain abdominal film showing typically fragmented stone of Figure la after ESWL; contour of stone 
has changed and is shaped to ductal pattern. 
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Pain relief: Only patients who reported no further pain attacks in the upper abdomen and 
absence of continuous pain were scored as having pain relief. Of the 13 patients with stone 
fragmentation, II (85 %) had immediate pain relief after ESWL, while two (15 %) had not. 
All 4 patients without fragmentation, had no pain relief after ESWL. 
Stone clearance: Seven patients (41 % of all patients) eventually had complete stone 
clearance. This was achieved either spontaneously (3 patients) or following endoscopic 
extraction and lavage with saline through a naso-pancreatic drain (4 patients; Table 3). 
Table 2 
Results after ESWL of pancreatic stones in 17 patients with chronic calcifying pancreatitis. 
Initial Pain Surgery 
pain recurrence 
n relief 
Stone fragmentation: 13 
With complete 
clearance 7 617 017 017 
Without complete 
clearance 6 5/6 3/6 3/6 
No fragmentation 4 0/4 4/4 3/4 
n: number of patients 
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Table 3 
Follow-up of 7 patients with stone clearance after ESWL of pancreatic stones. 
Pat Stone pain duration remarks 
clearance relief follow-up 
after (months) 
ESWL 
Endoscopic 
extraction 
and flushing yes 59 still pain-free 
3 Spontaneously yes 52 still pain-free 
7 Endoscopic 
extraction 
and flushing yes 44 pain-free: 1 pain attack 
after alcohol consumption 
8 Endoscopic 
extraction 
and flushing yes 34 still pain-free 
9 Endoscopic 
extraction 
and flushing no 30 pain-free: last 25 months 
13 SpontaneousI y yes 18 still pain-free 
15 Spontaneously yes 14 still pain-ftee 
pat: patient. 
1..000- term results 
The mean duration of follow-up after ESWL for all patients was 30 months (range: 12-59 
months; Table 1). 
Patients with ductal clearance: All 7 patients were free of pain at follow-up (Table 3): 
patient 9 was the only patient with persistent pain immediately after successful ESWL. 
However, at 15 and 30 months follow-up he reported to be free of abdominal pain. 
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Patients without ductal clearance: Three of the 6 patients, in whom stone fragmentation did 
not result in complete clearance, had recurrent pain attacks at 12, 24 and 5 months after 
ESWL (patients 2, 6, and 16, respectively). Plain abdominal films still showed major 
calcifications and they consequently underwent a side-to-side pancreato-jejunostomy. One 
patient (#17) never experienced pain relief since ESWL and repeated endoscopic attempts to 
clear the pancreatic duct or to place an endoprosthesis failed, so a surgical drainage procedure 
is now contemplated. 
Surgery: At follow-up, 6 patients underwent surgery; 3 directly after failure of ESWL and 
3 after recurrent pain attacks. Of these patients, 2 are pain free, 3 have only partial pain relief 
and I has no pain relief at all. One patient has developed an insulin dependent diabetes 
mellitus. 
Complications 
The only complication related to ESWL was an exacerbation of pancreatitis in patient 6 with 
an increase of her serum amylase level up to 3690 lUll (normal: < 130 lUll). The 
pancreatitis resolved rapidly with medical management in 3 days and this patient was 
discharged in good condition 4 days later. The mean serum amylase levels 
(standard error) of the other patients dropped from 304 (117) lUll to 206 (105) lUll after 
ESWL (p<0.01, Wilcoxon test). Other laboratory parameters did not differ significantly 
before and after the ESWL treatment (p > 0.1 in all cases). 
Case report 
Of special interest is the case of patient 13, a 19 years old woman with idiopatic, recurrent 
pancreatitis since childhood. Eventually she developed multiple pancreatic stones. She suffered 
from chronic upper abdominal pain with frequent exacerbations which were difficult to 
control. Twenty months before ESWL treatment she underwent a left pancreatic resection and 
a pancreato-jejunostomy. However, she kept suffering from abdominal pain attacks, which 
required morphinomimetic medication. At ERCP multiple stones with a low grade of 
calcification were seen in the ducts of the uncinate process (Figure 2a). Resection of the head 
of the pancreas would almost inevitably have led to complete pancreatic insufficiency. We 
decided to treat her with ESWL using contrast medium via the naso-pancreatic drain to 
localize the stones. After 4 ESWL sessions no stone material could be demonstrated anymore 
(Figure 2b) and 18 months later she was still free of upper abdominal pain. 
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Figure 2a: ERCP of patient 13 before ESWL~ multiple stones in the uncinate process of the pancreas. 
Figure 2b: ERCP of patient 13 after ESWL; clearance of the small pancreatic ducts in the uncinate 
process. 
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DISCUSSION 
Seventeen patients with CCP were treated with ESWL. Eleven patients (65 %) were free of 
abdominal pain directly after the treatment. Although it remains uncertain whether pancreatic 
stones are the main cause of the pain in CCP, we observed a clear relation between stone 
fragmentation and the relief of upper abdominal pain in our patient series (II out of 13 
patients; Table 2). 
The question whether long lasting pain relief will follow stone fragmentation without complete 
ductal clearance remains to be answered. In our series 3 patients with stone fragmentation 
without complete clearance (2, 6 and 16) had an operation 12, 24 and 5 months after ESWL, 
respectively, because of recurrent abdominal pain. In the other 3 patients with only stone 
fragmentation (12, 14, and 17) the duration of follow-up is still short (Table I) and patient 
17 probably will be operated in the near future because he still reports on abdominal pain. 
This suggests, that fragmentation alone results in pain relief only on short term and recurrence 
of symptoms becomes more probable at longer follow-up. Recurrence of symptoms is not 
necessarily related to the presence of remaining fragments but can also very well be due to 
strictures in the pancreatic duct. Here, stent placement has proven to be a viable alternative 
to a surgical drainage procedure, especially in cases of ductal strictures in the bead of the 
pancreas with upwards dilatation (14). 
In 41 % of our patients ESWL resulted in clearance of stone material. Also on long term these 
results seem promising: none of these patients had an operation yet, and almost all of them 
are free of pain after ESWL. Only one patient still had complaints directly after ESWL, which 
subsided in the following months (Table 3). 
Advantages of ESWL compared to an operation are the following: It is minimally invasive, 
there is usually no need for general anesthesia and the number of complications is low (in our 
series I exacerbation of pancreatitis). The hospitalization time is short (about 3 days per 
ESWL session) and finally, to date there have been no reports on severe complications or 
mortality caused by ESWL. 
Also in other institutions ESWL of pancreatic stones has been reported with fair initial results. 
Sauerbruch et al. (15) reported their initial experience with ESWL in 8 patients. 
Fragmentation was successful in 7 cases and complete clearance was achieved in 4. Three of 
the 8 patients had complete relief from abdominal pain attacks. Their latest results are similar 
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to ours with complete clearance in 42% and partial clearance in 29% (16). Soehendra et 
al.(I7) achieved stone clearance in all of their 8 patients and 6 of them remained pain free 
during a follow-up period of 2 to 8 months. Neuhaus et al.(18) reported stone fragmentation 
in all of their 12 patients and stone clearance in 8 cases. After a median follow-up of 8 
months 5 of their patients remained continuously free of pain. Recently, Delhaye et a1.(19) 
reported on a group of 123 patients with CCP treated with ESWL and subsequent endoscopic 
drainage. They achieved stone fragmentation in 99% and stone clearance in 59% of their 
patients. In order to achieve these good results they emphasize the importance of deep 
endoscopic drainage in the pancreatic duct after ESWL. Furthermore, they conclude that their 
results in fact are equal to those achieved with an operation. Indeed, an operation for pain 
relief in CCP does not always lead to the expected result: in our series 4 out of 6 patients, 
who had an operation after ESWL, still had abdominal pain. This is probably due to patient 
selection but also in large series of patients operated for CCP, long lasting pain relief cannot 
be achieved in 20-40% of the cases (3,8,9,20,21). The benefit of an operation in CCP is thus 
debatable (4). 
We conclude that, if endoscopic extraction of stones in the pancreatic duct turns out to be 
impossible, ESWL associated with endoscopic drainage should be chosen first before surgery 
is considered. The main indication is a calcified stone leading to main pancreatic duct 
obstruction but also multiple radiolucent stones in the minor ducts can be treated as shown 
in our series. Furthermore, we conclude that it seems important to achieve complete ductal 
clearance of stones and not mere stone fragmentation. Remaining strictures may require 
stenting. Longer duration of follow-up and a larger number of patients will have to confirm 
this in the future. Of course, abuse of alcohol should also be treated to maintain success of 
this therapy of CCP. 
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ABSTRACT 
Since the early 1980s, extracorporeal shock wave lithotripsy (ESWL) has partially replaced 
major operative procedures in various fields of surgery. In the interest of the patient, it is 
important to determine the exact role of ESWL in surgery. Comparing our own prospectively 
followed patients with other patient series, we have tried to assess this role. We treated 133 
patients with cholecystolithiasis, 80 patients with choledocholithiasis, and 17 patients with 
pancreatic stones using a second generation lithotriptor, the Siemens LithestaT'" (Siemens, 
Erlangen, Germany). 
The results suggest a limited role of ESWL for cholecystolithiasis, in which it is reserved for 
patients with high operative risk and patients who reject an operation. For choledocholithiasis 
ESWL seems to become an integral part of the treatment in the elderly patient in whom 
endoscopic stone removal proved impossible. Finally, ESWL could become a first option for 
the treatment of intractable pain in patients with chronic calcifying pancreatitis. 
INTRODUCTION 
Shock waves, which can be used to disintegrate stones because of their physical 
characteristics, can be generated by 3 methods (1-3). 
Since 1980 extracorporeal shock wave lithotripsy (ESWL) has been used in the case of 
urolithiasis and has replaced surgical treatment almost entirely (4,5). ESWL of gallbladder 
stones has been applied since 1985 (6,7), and the first reports on ESWL of common bile duct 
stones and pancreatic stones appeared in 1989 (8,9). Despite the initial enthusiasm, 
restrictions for ESWL of gallbladder stones especially soon became evident. Rigid entry 
criteria, expensive adjuvant dissolution therapy, moderate results, and the possibility of stone 
recurrence after gallbladder-preserving therapies are major drawbacks (7,10-17). 
ESWL of common bile duct stones is useful in patients in whom endoscopic removal proves 
impossible (8,18-21). ESWL of pancreatic stones in chronic calcifying pancreatitis (CCP) is 
still relatively unknown but seems effective (22). The morbidity and mortality associated with 
ESWL are minimal (7,8, 11 -13, 18-22) and compare favorably to those with surgery. Therefore 
we have tried to assess the exact role of ESWL in this field with our own prospectively 
followed patients and other patient series. 
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PATIENTS AND METHODS 
Using a so-called second-generation lithotriptor, the Siemens Lithostar" (Siemens, Erlangen, 
Germany), which operates on a electromagnetic principle, we treated patients suffering from 
cholecystolithiasis (n=133, group I), choledocholithiasis (n=80, group II), and pancreatic 
stones (n=17, group III). Characteristics of these patients are depicted in Table I. and entry 
criteria for ESWL in the three groups are shown in Table 2. 
Group I 
All patients were treated on an outpatient basis. Directly after the first ESWL-session, 
adjuvant oral bile acid (OBA) therapy (urso-and chenodeoxycholate) was started. Ten days 
after each session an ultrasound examination (US) was done to determine the fragmentation 
result; If fragments remained larger than 5 mm after repeated sessions, ESWL was considered 
a failure, and cholecystectomy was advised. US was performed at regular intervals (3 months. 
6 months, I year, 1.5 years. and 2 years) after the first session. If US did not demonstrate 
stone material at 2 consecutive occasions, clearance of the gallbladder was assumed and the 
OBA therapy stopped. 
Group II 
All patients had I or more of the symptoms, depicted in Table 1. 
The stones were visualized by radiology and injection of contrast medium in the bile ducts via 
a biliary drain (Table 1). In 11 patients the biliary sphincter could not be reached at 
endoscopy. In those patients and in 7 others, percutaneous drains and T-tubes were used. Of 
the 47 patients without gallbladder, 12 had had a cholecystectomy recently and had also 
undergone a choledochotomy. In these patients, overlooked common bile duct stones were 
discovered on a postoperative T -tube cholangiogram. The possibility of spontaneous clearance 
of the stones after endoscopic sphincterotomy was thougt to be low because of the large size 
and impacted character of the stones. All treatments were performed under antibiotic coverage 
and continuous lavage of the bile ducts with 4 liters of sterile water per 24 hours. Shortly 
after ESWL the result was evaluated by cholangiography. In case of fragmentation (reduction 
of stone diameter, lines of contrast medium visible within the stone, or quick disappearance 
of the contrast medium from the biliary tree), cholangiography was repeated after 2 days of 
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lavage. In the case of remaining fragments, a new endoscopic or percutaneous stone extraction 
was attempted. If it was not successfull or in cases where stone fragmentation was never 
demonstrated, the patient underwent an elective bile duct exploration or had an endoprosthesis 
placed in the common bile duct. 
Table 1 
patient characteristics before ESWL treatment. 
Characteristic Group I Group II Group III 
Patients (MIF) 133 (34/99) 80 (33147) 17 (1017) 
Mean age (range) 49y (24-81) 73y (27-91) 42y (19-55) 
Stones (no. patients) 
1 70 (53%) 34 (43%) 6 (35%) 
2-5 55 (41 %) 32 (40%) 7 (41%) 
6-10 8 (6%) 14 (18%) 4 (24%) 
Mean diameter of 
stone (range) 17mm (5-40) 25mm (10-50) 21mm (14-40) 
Patients (no) with 
ES 69 (86%) 17 (100%) 
Biliary drain 
NBD 62 (78%) 
PTD 6 (8%) 
T-tube 12 (15%) 
Symptoms 
biliary colics 39 (49%) 
jaundice 36 (45%) 
fever > 38.5 c. 16 (20%) 
Cholecystectomy 47 (59%) 
Previous pancreatic surgery 3 (18%) 
History of alcohol abuse 10 (59%) 
m: male~ f: fema1e~ y: years; no: number~ ES: endoscopic sphincterotomy; 
NBD: naso-biliary drain: PTD: percutaneous transhepatic drain. 
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Table 2 
Criteria for ESWL of gaJlbladder. common bile duct. or pancreatic stones. 
Gallbladder stones 
Symptoms: biliary colies 
Opacification of gallbladder at oral cholecystography 
No. of stones: 1-10; diameter of largest stone> 5 mm 
Calcified rim of stone < 2 mm 
No cholecystitis. cholangitis. pancreatitis, or concomitant 
choledocholithiasis at the time of ESWL 
Common bile duct stones 
Symptoms: obstruction of common bile duct Gaundice, abdominal pain. fever) 
Endoscopic extraction impossible 
Visualization of stones with contrast medium via a biliary drain 
Pancreatic stones 
Symptoms: recurrent abdominal pain 
Endoscopic extraction impossible 
Visualization of stones without contrast medium 
No acute pancreatitis, acute cholecystitis, cholangitis, or concomitant 
choledocholithiasis at the time of ESWL 
Gallbladder', common bile duct, and pancreatic stones 
No lung tissue, cysts, or aneurysms in the shock wave path 
No bleeding disorders 
No pregnancy 
Group III 
The diagnosis 'chronic pancreatitis' was based on the patient's history (chronic upper 
abdominal pain or recurrent attacks of upper abdominal pain), the presence of calcifications 
in the pancreatic region on plain abdominal roentgenography, and the radiologic aspect of 
chronic pancreatitis on endoscopic retrograde cholangiopancreatography (23). All patients 
were treated under antibiotic coverage. In 15 patients the stones could be visualized as 
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calcifications by radiology alone. Shock waves were focussed on these calcifications. In 2 
patients additional injection of contrast medium via a nasa-pancreatic drain was necessary for 
visualization of the stones because of a low calcification grade. After the ESWL treatment a 
plain abdominal roentgenogram was obtained. If stone fragmentation was observed. (clear 
change of contour of stone), another endoscopic stone extraction was attempted, after which 
a nasopancreatic drain was left in place for lavage (2 liters sterile water per 24 hours). If no 
stone material was observed, spontaneous clearance of the duct was assumed. If ESWL 
repeatedly failed in fragmenting the stones, an operation was contemplated. 
Statistics were performed using the test for comparing proportions with binominal distributions 
and the Wilcoxon test for matched pairs. 
RESULTS 
Table 3 summarizes the characteristics of the ESWL sessions for all three groups of patients. 
Table 4 depicts the fragmentation and clearance rates for all three groups. For group I the 
median follow-up (range) is 14 months (1-45 months), in group II 23 months (1-50months) 
and in group III 20 months (3-41 months). 
GrouP I 
Stone fragmentation (decrease of diameter of the largest stone> 25%) could be achieved in 
most patients (89%); but after adjuvant OBA therapy stone clearance could be achieved in 
only 32% of the patients to date. In the remainder of the patients, OBA therapy continues or 
a cholecystectomy has been undertaken because of persistent biliary complaints or insufficient 
stone fragmentation. Patients with a solitary stone had a significantly better chance to become 
stone-free than patients with multiple stones: 26 of 52 (50%) versus 5 of 60 (8,3%), 
respectively, after I year of follow-up (p <0.001: two sample proportion test). 
Fourteen percent of patients with stone clearance (6/43) had stone recurrence: four of the six 
were not symptomatic, one underwent a cholecystectomy and in one OBA therapy was 
restarted. 
A total of 57 patients (43%) had biliary colic shortly after the ESWL treatment. Other 
complications were obstruction of the common bile duct in nine patients (7%), five of whom 
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became jaundiced and in four of whom pancreatitis developed. Two patients (1.5 %) had 
transient hematuria, one had acute cholecystitis after ESWL. OBA therapy resulted in diarhea 
in 15 patients (11%), which resolved in all cases after lowering the dose of OBA for 2 weeks. 
No mortality was observed. 
Group II 
Stone clearance was achieved in 52 patients (65%); in 14 cases biliary lavage was sufficient 
to clear the bile ducts; in 34 cases the remaining fragments were extracted endoscopically and 
in 4 cases percutaneously. In case of failure of the additional endoscopic or percutaneous 
attempts (n=14, 18%), the final treatment -taking into account the patient's physical status-
consisted in placing an endoprosthesis past the fragmented stones (n=6) or undertaking an 
elective bile duct exploration (n=6). In two cases emergency surgery was necessary after 
complications of an endoscopic procedure (one perforation of the common bile duct with a 
Dormia basket, one arterial bleeding after extension of a sphincterotomy). These two patients 
had an uneventful recovery. 
Two patients (3%), one with and one without a gallbladder, had stone recurrence at 27 and 
30 months after ESWL, respectively. The first patient could be treated with a renewed 
endoscopic extraction, and the other had a successful repeated ESWL treatment. 
One patient had a subcapsular hematoma of the right kidney, as demonstrated on US. The 
hematoma resolved without clinical consequences. Notwithstanding antibiotic prophylaxis one 
patient developed sepsis with a positive blood culture (E. coli). This patient received adequate 
medical treatment. There was no mortality after ESWL and adjuvant treatments. 
Group III 
Thirteen patients had stone fragmentation (76%), of whom II (65%) had immediate pain 
relief after ESWL. The other two patients, with fragmentation but without clearance of stones, 
had recurrent pain attacks and consequently underwent a side-to-side pancreatojejunostomy 
12 and 24 months after ESWL, respectively (Table 4). Seven patients (41 %) had complete 
stone clearance (in three the pancreatic duct cleared spontaneously after ESWL, and in four 
the duct was cleared after 2 days of lavage with sterilized water). To date, none has had 
recurrent abdominal pain except one patient who had a pain attack after a large alcohol intake. 
The median follow-up of these seven patients was 22 months (6-41 months). Of the four 
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patients without stone fragmentation, three had a side-to-side pancreaticojejunostomy. 
However, all 3 of them still report abdominal pain at 38, 31, and 14 months after the 
operation, respectively. One has developed insulin-dependent diabetes mellitus. 
The only complication directly after ESWL was an exacerbation of pancreatitis in one patient 
that could be treated medically. Again, there was no mortality after ESWL. 
Table 3 
Characteristics of ESWL sessions in 3 groups of patients. 
Group I Group II Group III 
Characteristic (n; 133) (n;80) (n;17) 
Sessions/patient 2.2 (1-7) 1.9 (1-4) 1.9 (1-4) 
(range) 
SW Isession 2817 4703 4660 
range: 75-4000 1200-6000 1000-8000 
Duration/session 62 min 64 min 73 min 
range: 35-210 30-150 20-105 
Patients (no) 
GA 0 1 1 
AS 133 71 15 
No GAlAS 0 8 1 
SW: shock waves: min: minutes: no: number; GA: general anaesthesia; AS: analgo-sedation. 
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Table 4: results of ESWL of gallbladder. common bile duct and pancreatic stones. 
Group no fragmentation fragmentation 
-
stone clearance 
I (n= 133) IS (JI %) Jl8 (89%) 
-
43 (32%) 
8 expectant 52 still OBA 6 recurrence 
7 operated 23 operated 4 expectant 
1 operated 
IOBA 
II (n=80) 14 (18%) 66 (83%) 
-
52 (65%) 
all operated 6 endoprosth 14 lavage 
electively 6 operated electively 34 endoscopic extraction 
2 operated emergently 4 percutaneous extraction 
III (n=17) 4 (24%) 13 (76%) 
-
7 (41 %) 
1 expectant 4 pain relief all pain relief 
3 operated 2 operated 
OBA: oral bile acid therapy; endoprosth: endoprosthesis. 
DISCUSSION 
The role of ESWL in surgery is becoming clarified. With the results achieved in our patients 
and in other patient series, more reasoned statements can be made now. Instead of optimistic 
or pessimistic views, patients benefit most from a well established treatment scheme in which. 
the different modalities have their own, though sometimes limited, role. 
Gallbladder stones 
(Laparoscopic) cholecystectomy remains the gold standard as the treatment for symptomatic 
cholecystolithiasis (24,25). Cholecystectomy carries morbidity and mortality rates of about 
10 to 30% and 0.1 to 0.3%, respectively, and these rates increase with age (25). With 
laparoscopic cholecystectomy these figures may be lower, but the higher incidence of bile duct 
injuries gives reason for concern (26). There is no reported mortality associated with ESWL 
of gallbladder stones, and the rate of major complications is low (7,11). In our series, nine 
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patients (7%) had common bile duct obstruction, and one patient had an acute cholecystitis 
after ESWL, 
After optimistic initial reports in which fmally more than 90% of the selected patients became 
stone- free (7), less favorable results gave rise to pessimistic comments (27). However, most 
patient series have reported overall stone-free rates at 12 months of 30 to 84 %, depending 
largely on stone characteristics (10-14, 28-31). This point is in accordance with our own 
findings, that ESWL therapy is found to be more effective for solitary than multiple stones, 
for radiolucent than slightly calcified stones, and for smaller than for larger stones. In view 
of the above, we think that only patients with a high operative risk (ASA classification III-IV, 
(32)) or patients who reject an operation should undergo ESWL, provided they comply with 
strict criteria to achieve the highest possible stone clearance rate. We estimate this rate to be 
about 50 % after I year. 
Common bile duct stones 
In the case of choledocholithiasis, surgical common bile duct exploration is an accepted 
therapy but carries a considerable mortality rate, which may be as high as 8% in the elderly 
or in high-risk patients (33-35). Among this population, the treatment of choice is endoscopic 
sphincterotomy (ES) (36-38). However, in about 10% of the cases it proves impossible to 
clear the bile ducts with endoscopy alone (8,36,39). The natural history of common bile duct 
stones, with or without ES, still is not well known (37). However, all our patients were 
symptomatic and needed therapy for the short term. In these patients ESWLis an attractive 
alternative to surgery: stone clearance was achieved in 65 % of our patients and in up to 88 % 
in other studies (8,18-21,40,41). 
The failure rate can be due to the possibility of false positivity during radiologic targeting via 
a biliary drain. The morbidity rate of ESWL of common bile duct stones is low: 
macrohematuria (in 2-11 % of the patients) and hemobilia (2-8%), are reported to resolve 
within a few days (8,18,20). Septic fever in 3 to 6% of the cases is often regarded as an 
exacerbation of already existing cholangitis (8,18,19). There has not been any ESWL-related 
mortality, but mortality associated with the adjuvant endoscopic or percutaneous procedures, 
which is about 1% (36,39), must be borne in mind. At least for the patient with an increased 
operative risk, ESWL should be considered before surgery after failure of endoscopic 
measures. 
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Pancreatic stones 
Although it remains uncertain whether pancreatic stones are the main cause of the pain in 
chronic calcifying pancreatitis (CCP), 11 of 13 patients with stone fragmentation were free 
of abdominal pain directly after the ESWL treatment (Table 4). Whether fragmentation 
without stone clearance can lead to long lasting pain relief is doubtful. In our series two of 
six patients with stone fragmentation but no stone clearance had recurrent abdominal pain and 
an operation after ESWL. The other four patients have reported pain relief only at limited 
follow-up (median 7 months, range 5-10 months]). ESWL resulted in clearance of stone 
material in 41 % of our patients, and all of them have pain relief to date. 
Stone clearance in 59% of 123 patients with CCP, treated with ESWL and subsequent 
endoscopic drainage, has been reported recently (22). The authors emphasized the importance 
of deep endoscopic drainage in the pancreatic duct after ESWL. 
The ESWL technique compares favorably with an operation for pain relief in CCP: it is 
noninvasive, there is no need for general anesthesia, no mortality has been reported, and the 
number of complications is low (in our series one exacerbation of pancreatitis). It is unlikely 
that pancreatic insufficiency will be induced by ESWL. Furthermore, the hospitalization time 
is short (about 3 days per ESWL session). Pancreatic surgery is accompanied by considerable 
morbidity and mortality (rates of 20-40% and 2-5%, respectively) (42,43). In large surgical 
series, long-lasting pain relief cannot be achieved in 20% to 40% of the cases (42-46). In 
view of the above, a randomized trial comparing ESWL with surgery or the natural history 
of this disease is warranted. 
In conclusion, if a decision must be made about whether to operate on a patient with CCP or 
treat him or her with ESWL followed by endoscopic drainage, we think that ESWL is the 
better alternative. It seems important to achieve stone clearance and not mere stone 
fragmentation. Of course abuse of alcohol must be treated as a condition that may interfere 
with the success of this therapy of CCP. 
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ABSTRACT 
Objective: To evaluate our diagnosis and treatment of proximal cholangiocarcinorna. 
Design: Retrospective clinical study. 
~ Department of Surgery, University Hospital. 
Subjects: 66 patients with proximal cholangiocarcinoma [median age (range): 64 years (28-
87)]. 
Interventions: mtrasonography (n =65), computed tomography (n =55), endoscopic retrograde 
cholangio-pancreaticography [ERCP] (n=54), percutaneous transhepatic cholangiography 
[PTC] (n=32), angiography (n= 19) and cytology (n= 13) were used in diagnosis. Treatment 
consisted of: insertion of a stent (n=37), resection of the tumour (n= 16), and biliary-enteric 
anastomosis (n=9). Twenty eight patients received radiotherapy, three patients received no 
active treatment. 
Main outcome measures: Usefulness of diagnostic methods, survival. 
Results: mtrasonography, ERCP and PTC were helpful whereas computed tomography, 
angiography, and cytology added little additional information. Mean (SEM) survival after 
resection was 35.8 months (7.4) and after consevative treatment 10.4 months (1.5) (p 
<0.001). 
Conclusion: A multidisciplinary approach is necessary and the tumour should be resected if 
possible. 
INTRODUCTION 
Nearly all tumours of the biliary tree are sclerosing, nodular or papillary adenocarcinomas 
(21). They spread perineurally, through local lymph nodes and the subepithelial plane of the 
bile ducts and often produce an extensive local fibrotic reaction (21). In a later stage of the 
disease they spread to distant nodes. Obstructive jaundice caused by obstruction of the bile 
ducts is almost invariably the first sign of the disease (I). Cholangiocarcinomas carry a poor 
prognosis, most patients dying within a year of diagnosis and an overall survival rate of about 
8% at five years (20). There has been an obvious tendency to move from palliative to radical 
treatment since the introduction of improved and advanced pre-operative imaging techniques 
like ultrasonography (US), computed tomography (CT), percutaneous transhepatic 
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cholangiography (PTC), endoscopic retrograde cholangio-pancreaticography (ERCP) and 
angiography. 
At present resection is the treatment of choice (3,16); this includes resection of most of the 
extrahepatic bile duct, often with removal of the left and right hepatic ducts. To obtain 
resection margins that are free of tumour, resection of segment I (or segment IV or both) is 
often necessary. The sUIvival for patients with clear resection margins is better than that for 
patients in whom they contain tumour (2,5). Biliary-enteric continuity should be re-established 
with a Roux-en-Y hepaticojejunostomy. About 20% of proximal cholangiocarcinomas are 
suitable for radical resection (7). The rest of the patients have lymph node involvement or 
liver metastases diagnosed preoperatively. Ingrowth into the portal vein or hepatic artery 
(main trunk or both branches), and extension of the tumour past secondary bifurcations of the 
biliary tree in both the left and the right lobes of the liver are almost always signs of 
unresectability (6). Finally, a number of patients are not fit enough to be able to survive such 
an operation. In these cases palliative treatment will be necessary to secure flow of bile into 
the duodenum. Treatment options are percutaneous (for proximal strictures: left or right 
hepatic ducts) or endoscopic (for distal strictures: common hepatic duct, common bile duct) 
insertion of stents through the obstructed bile ducts (19). A biliary-enteric anastomosis can 
also bypass the obstruction. Both external and internal (for example intraluminal placement 
of 192-iridium wire) radiotherapy are useful after both palliation and resection. 
We describe here 66 consecutive patients who attended our hospital for treatment of proximal 
cholangiocarcinoma over a period of 10 years. 
PATIENTS AND METHODS 
We evaluated the medical records of 66 patients who were diagnosed in our hospital with a 
proximal or mid-ductal cholangiocarcinoma from 1980 to 1990, and their details are shown 
in Table I. 
Diagnostic procedures (Table II) 
The most commonly used diagnostic tool was US, and most patients had CT and ERCP. In 
only 13 patients could material for cytological examination be obtained: in nine by ultrasound 
guided puncture and in four by endoscopic brushing. 
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Table I 
Details of the 66 patients with proximal cholangiocarcinoma. 
Figures are number (%) of patients unless otherwise stated. 
Sex: 
Male 
Female 
Median age (years): 
Range 
Diagnosis: 
Histologically confIrmed 
Clinical alone 
Presenting symptoms: 
Obstructive jaundice 
Prominent abdominal pain 
Haemobilia 
Non-specific symptoms: 
Loss of weight 
Vague abdominal pain 
Fatigue 
Table II 
28 (42) 
38 (58) 
64 
28-87 
46 (70) 
20 (30) 
62 (94) 
3 (4) 
I (2) 
35 (53) 
32 (48) 
20 (30) 
Diagnostic procedures in 66 patients with proximal choiangiocarcinoma. 
Procedure 
Ultrasonography 
Computed tomography 
ERCP 
PTC 
Angiography 
Cytology 
No (%) of patients 
65 (98) 
55 (83) 
54 (82) 
32 (48) 
19 (29) 
13 (20) 
98 
Treatment (Table III) 
Resectability of the turnoUT was assessed from the results of the investigations and patients 
were assigned to the appropriate treatment. Table III summarises the different initial 
treatments. Thirty seven patients were given a permanent stent as palliation. In 12 patients it 
was possible to bypass the obstruction with an endoprosthesis; in seven cases this was done 
endoscopically and in five percutaneously. In five patients. only external, percutaneous 
drainage was possible and 20 required a combination of both internal and percutaneous 
drrunage to relief the obstruction to the biliary tree. Sixteen of these 37 patients received 
radiotherapy; three patients received only external beam radiation (dose: 40 Gy in 16 fractions 
of250 cGy), two patients received only intraluminal radiation through a stent (insertion of 192_ 
iridium wire, dose: 25 Gy at 1 cm) and 11 patients were given a combination (40 Gy 
externally, 25 Gy by iridium wire). The criterion for radiotherapy after resection was 
microscopic evidence of residual tumour in the proximal resection plane without hepatic or 
lymph node metastases. Of the 16 patients treated by a resection, six met this criterion; two 
were given 40 Gy externally and four 40 Gy externally and 25 Gy at 1 cm through a 
postoperative drrun. Of the nine patients treated by biliary-enteric anastomosis five received 
radiotherapy (two were given 40 Gy externally and three 40 Gy externally and 25 Gy at I cm 
through a postoperative drrun). 
Table III 
Treatment of 66 patients with proximal cholangiocarcinoma. 
Treatment Total No No who received 
of patients radiotherapy 
Insertion of stent 37 16 
Resection 16 6 
Biliary-enteric anastomosis 9 5 
Radiotberapyalone 1 1 
No treatment 3 0 
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In four of the 16 patients treated by radical resection and in six of the nine treated by biliary-
enteric anastomosis, a stent was inserted beyond the turnoUT to achieve preoperative relief of 
the jaundice. 
Fifty patients were unsuitable for radical resection: in 25 the tumour was too extensive or 
metastases were diagnosed before operation could be contemplated; 11 were too old or not 
fit for a major operation; and in nine the tumour was inoperable at laparotomy. One patient 
refused blood transfusion on religious grounds, and in four the reason was not known. 
The significance of differences between groups was assessed by the Mann-Whitney and the 
Wilcoxon tests. Survival analysis was by the logrank test. 
RESULTS 
Diagnostic procedures 
US showed dilated bile ducts in 85 % of patients with obstructive jaundice (Table IV). A hilar 
mass was seen in only about a third of cases, but the percentage increased if CT was also 
done. Both ERCP and PTC suggested malignancy in almost all cases. In one case ERCP 
failed and in another suggested sclerosing cholangitis rather than malignant stenosis. 
Cytological aspiration yielded malignant cells in only a few cases. Angiography was done in 
19 cases; on two occasions it showed involvement of the hepatic artery and in one 
involvement of the portal vein. The latter was also diagnosed by US. 
The sites and classification of the tumours are given in Table V. 
100 
Table IV 
Number (%) of diagnostic procedures which suggested proximal choiangiocarcinoma in 66 patients. 
Procedure Total No 
Ultrasonography 65 
Computed tomography 5S 
ERCP 54 
PTC 32 
Cytology 13 
Table V 
No (%) that suggested malignancy 
Dilated bile ducts 
Hilar mass 
Hilar mass 
Presence of tumour 
Presence of tumour 
Malignant cells 
55 (85) 
20 (31) 
24 (44) 
52 (95) 
31 (97) 
3 (23) 
Sites and classification of the 66 cholangiocarcinomas. Figures are number (%) of patients. 
Site of tumour: 
Junction of right and left hepatic duct 
Common hepatic duct 
Proximal common bile duct 
Classification (5): 
Type I (at junction of right and left hepatic duct, not obstructed) 
Type II (at junction of right and left hepatic duct with obstruction) 
Type III (extension past secondary bifurcations in right or 
left hepatic duct, or both) 
Unknown 
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47 (71) 
14 (21) 
5 (8) 
2 (3) 
14 (21) 
37 (57) 
13 (20) 
Treatment of patients (Figures 1&11) 
Figure I shows the survival of the 37 patients treated by insertion of a stent divided into those 
treated by stent insertion alone (n=2l) and those treated by stent insertion and adjuvant 
radiotherapy (n= 16). Median survival for the whole group was 5.3 months (range 0.7-44.0) 
(Table VI). 
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Figure I: Survival after insertion of sten!. The dashed line indicates those who were treated with 
radiotherapy (n= 16). the dotted lines those who were not (0=21), and the solid line shows the 
cumulative survival (0;::;:37). 
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Of the 37 patients treated by insertion of a stent, mean total bilirubin concentration before, 
and I, 3, 6, and 12 months after insertion were 268 I'molll (n=37), 91 I'molll (n=23), 
941'molll (n=14), 73 I'molll (n=13), and 27 I'molll (n=IO), respectively, 
Twenty three patients required renewal of their stents (mean: 3.0 new stentsfpatient). Among 
the 21 patients treated by stent insertion alone, the frequency of stent replacement was 11115 
days, whereas in the group of 16 who had adjuvant radiotherapy it was 11149 days, 
Complications in the 62 patients who were treated by some form of intervention are shown 
in Table vr, and figure 2 shows survival curves for those who had resections (n=16) 
compared with all other forms of treatment (n=47), 
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Figure 2: Survival after resection (dashed line, n= 16), and all other treatments (solid line, 0;::::47). 
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Table VI 
Results of treatment in 62 patients who had some form of intervention, 
Median 
survival 
(months) 
Range 
No of 
operative 
deaths 
Complications 
Blockage 
of steflt 
Cholangitis 
Wound 
infection 
Haemorrhage 
Anastomotic 
leak 
RT: Radiotherapy 
Insertion of stent 
(n=37l 
With 
RT 
(n= 16) 
13.8 
1.8-40.2 
Without 
RT 
(n=21) 
3.0 
0.5-44.0 
Total 
5.3 
0.5-44.0 
Not applicable 
16 
23 
0 
0 
0 
Resection of tumour Biliary~enteric anastomosis 
(n-16) (n=9) 
With Without With Without 
RT RT RT RT 
(0=6) (0=10) Total (n=5) (0=4) Total 
20.4 29.4 23.4 9.9 8.3 9.9 
90.7-20.9 10.8-71.60.6-105.6 0.6-105.6 6.4-14.9 0.7-20. 
2 
Not applicable not applicable 
2 2 
4 4 
2 0 
0 
.. 
o 
rl 
DISCUSSION 
It is obvious that early detection of cholangiocarcinoma is of major importance: in patients 
who present with obstructive jaundice in the absence of biliary stones, malignancy in the area 
of the biliary tree should always be excluded, particularly if the patient has recently lost 
weight, or has vague abdominal symptoms, or both. In these patients US should be the first 
imaging procedure used (18). This was done in all but one of our patients and showed dilated 
bile ducts in 85% of cases (Table Ill). A hilar mass was detected by US in 31 %, but CT was 
more sensitive (44% of cases). Although CT is sensitive in defining liver atrophy in the case 
of hilar cholangiocarcinoma (8), the additional value of CT over US can be questioned, 
particularly if (in cases suspected of malignancy) US is done by an expert. Angiography did 
not improve on US in our group of patients. 
Both PTC and ERCP were highly sensitive in diagnosing malignancy (Table Ill), and in 
addition they can also be used for therapeutic interventions, for example, insertion of a stent. 
Whether to use PTC or ERCP depends on the skill and experience available in different 
centres. Another important factor is the level of obstruction: proximal obstructions (at the 
hepatic hilar confluence) can more easily be bypassed by PTC (19). This stresses the growing 
importance of the role of the interventional radiologist in diagnosis and treatment of hilar 
cholangiocarcinoma. Distal obstructions in the common bile duct demand the expertise of an 
experienced endoscopist. 
Cytology was done in only 20% of patients and with poor results: in only three out of 13 
patients were malignant cells found, so we did not find that cytology was helpful in 
confirming the diagnosis. 
The best treatment for cholangiocarcinoma is, in suitable patients, resection of the tumour: 
median survival in the 16 patients with a resection was 23.4 months, with five patients still 
alive at 24.3, 34.4, 48.2, 76.9, and 105.6 months after their operation, respectively. In the 
47 patients with non-resective therapy this was 6.4 months, with three patients still alive at 
17.2,25.2, and 40.2 months after their intervention (p <0.001). 
Figure 2 shows the survival curves of the 16 patients treated by resection compared with the 
47 patients treated with stent placement, a biliary-enteric anastomosis or radiotherapy. The 
three year survival was 30% for patients treated by a resection, even if the resection margins 
were not free of tumour and adjuvant radiotherapy was given. The patients treated by 
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resection had a significantly better survival rate than the rest of the patients (p < 0.05). If 
resection margins were free, survival was even better, five of the 10 patients being still alive 
after their operation. At longer follow-up this radical treatment could tum out to have been 
curative. Obviously a strict selection of patients was responsible for these figures: only 
patients who were physically fit, with moderate regional extension of tumour (mostly classes 
I and II) and without metastases underwent a radical resection. In our series 16 patients 
fulfilled these conditions (resectability rate: 24%). In other studies, comparable resectability 
rates were achieVed. Blumgart et al. (7) found resectable lesions in 18 of 94 patients (19%). 
Langer et al. (15) treated 90 patients of whom 69 were diagnosed as having proximal or mid-
ductal adenocarcinoma of the bile ducts. Eighteen of these 69 patients (26%) had resections. 
Lai et al (12) reported a resectability rate of 30% (29 of 97 patients with proximal bile duct 
cancer). Bismuth et al (5) did resections for 23 of 122 patients (19%) with hilar 
cholangiocarcinoma. 
One of our goals should be to detect these tumours at the earliest stage possible to increase 
the percentage of patients who are eligible for a resection. 
Because of the advanced stage of the disease most patients were eligible only for palliative 
treatment. Survival after insertion of a stent or a biliary-enteric anastomosis did not differ 
significantly (median survival: 5.3 months and 9.9 months, respectively), but the quality of 
life should be taken into account because of the duration of hospital stay and the serious 
morbidity after biliary-enteric anastomosis. 
Despite frequent episodes of cholangitis caused by blocking of the stent, insertion of a stent 
(either percutaneously or endoscopically) was adequate palliative treatment, giving a 
significant fall in serum total bilirubin concentration within a month (p <0.001). The recent 
introduction of self-expanding metal stents seems promising in spite of the considerable 
increases in cost. Better patency rates and lower replacement rates have been reported 
(13,17), as well as ease of insertion and reduced damage during insertion (11,14). 
Positive results have been described for the use of radiotherapy in addition to other treatments 
(9,10). Looking at the median survival and the survival curve (figure I) it could be claimed 
that radiotherapy did prolong life expectancy, though not significantly. Patient selection 
influences these figures here as well, because only patients in good condition were eligible 
for radiotherapy. Another possible advantage of radiotherapy could be to decrease the need 
for replacement of stents; it is conceivable that it inhibits tumour growth at the proximal and 
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distal ends of the stent. Patients who did not have radiotherapy (n=21) had their stents 
replaced about every 115 days, whereas those who had radiotherapy (n=16) required one 
stent every 149 days. Randomized studies will be necessary to establish the possible value of 
adjuvant radiotherapy in the treatment of proximal cholangiocarcinoma. 
We conclude that in hilar cholangiocarcinoma the limits of therapeutic potential, both in cure 
and in palliation, have stin not been reached. Interdis:iplinary cooperation is necessary for 
optimal treatment. 
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CHAPTER 9 
GENERAL DISCUSSION AND CONCLUSIONS 
111 
This thesis was written at a time where the therapeutic options for gallstones are rapidly 
changing. As most medical literature is a reflection of practice at the time of writing, this 
thesis also is: it offers solutions for current problems in a rapidly changing field. But it also 
is aimed at preventing too rapid change, as occurred in the introduction of laparoscopic 
cholecystectomy. Impressed by the short term results, both the medical world and patients left 
no choice but to adopt this technique as quick as possible. However, since almost all initial 
series of laparoscopic cholecystectomy have been reported by experts in the field, it is 
possible that the real results of laparoscopic cholecystectomy, especially with regard to 
complications such as intraoperative damage to the bile ducts, could turn out worse than those 
published recently in important medical literature. Furthermore, patient selection is still an 
important factor in the case of laparoscopic cholecystectomy, leading to more optimistic 
results as well. 
Randomised controlled trials should be performed in order to evaluate newly introduced 
techniques. Laparoscopic exploration of the common bile duct will be the next exciting 
development but introducing it in an uncontrolled fashion as well could lead to disastrous 
consequences with regard to iatrogenic bile duct lesions. Therefore in future it would certainly 
be wise to compare this technique with endoscopic stone extraction and ESWL. 
ESWL has proven to be a safe and integral part of the management of common bile duct 
stones: further research is warranted in increasing the success rate of ESWL of common bile 
duct stones: it is important to identify those factors found at endoscopy which influence the 
success rate of ESWL in a negative sense. Stone diameter and composition playa role but of 
greater importance are the diameter of the distal common bile duct and the papilla of Vater, 
the presence of a papillary stenosis and the length of this stenosis (unpublished observations). 
Prior knowledge of these factors may change the treatment strategy: then the first option will 
be either an operation or endoscopic insertion of a permanent stent in the common bile duct, 
depending on the physical status of the patient. 
The introduction of laparoscopic cholecystectomy has revived the discussion about the 
management of suspected common bile duct stones. Routine use of intraoperative 
cholangiography can be replaced by selective preoperative endoscopic cholangiography, based 
on clinical indicators. The role of intraoperative cholangiography as a road map for the 
surgeon who performs a laparoscopic cholecystectomy can be discussed; a considerable part 
of iatrogenic lesions of the common bile duct allready will occur before the common bile duct 
U2 
is canulated. 
ESWL for the treatment of the invalidating pain in chronic calcifying pancreatitis seems to 
be an underestimated technique; in view of the mortalility and morbidity of pancreatic 
operations and their success rate of about 60-80%, a treatment algorithm with ESWL as the 
first step will be fully justified. Allthough the main indication for ESWL is a calcified stone 
leading to obstruction of the main pancreatic duct, also other stones can be treated. 
Malignant obstruction of the bile ducts is a slow but almost always fatal disease. If 
cholangiocarcinoma can be diagnosed at the earliest possible stage, the resectability rate will 
be higher and also, the physical condition of the patient at operation will be better. This will 
lead to a higher percentage of curative operations. However, since the presenting symptom 
of this disease is almost always jaundice, tumor extension often allready is beyond the 
possibility of resection before the patient is diagnosed as having cholangiocarcinoma. To 
achieve the highest possible resectibiJity rate a combined effort of various specialists is 
absolutely necessary. 
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CONCLUSIONS OF THIS THESIS: 
I. ESWL of stones in the common bile duct is a rapid, non-invasive, and effective 
treatment with minimal discomfort for the patient. Both short and long term results are 
good. In case endoscopic removal of the stones proves impossible, ESWL should be 
undertaken, particularly in elderly or high risk patients, but also in younger patients. 
2. Laparoscopic cholecystectomy improves quality of life and symptomatology to the 
same degree but at an earlier stage than conventional cholecystectomy. From this point 
of view laparoscopic cholecystectomy is preferable to conventional cholecystectomy. 
3. From the point of view of complications laparoscopic cholecystectomy still has not 
proven to be superior to conventional cholecystectomy. Only a randomised controlled 
trial can adequately compare both techniques but it seems not very probable that it 
ever will be conducted. 
L Endoscopic papillotomy and ESWL together can achieve stone clearance in 97-99% 
of all patients with choledocholithiasis. If stones in the common bile duct are suspected 
in patients who will undergo laparoscopic cholecystectomy, then these stones should 
be managed in the preoperative period. 
If endoscopic extraction of stones in the pancreatic duct turns out to be impossible, 
ESWL associated with endoscopic drainage should be chosen first before surgery is 
considered. It is important to achieve complete ductal clearance and not mere stone 
fragmentation. 
ESWL for cholecystolithiasis should be reserved for patients with high operative risk 
and patients who reject an operation, provided they comply with strict criteria. For 
choledocholithiasis ESWL becomes an integral part of the treatment in the elderly 
patient in whom endoscopic extraction proves impossible. ESWL could become a first 
option for the treatment of pain in patients with chronic calcifying pancreatitis. 
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7. Only a combined effort of surgeon. gastroenterologist, radiologist, and radiotherapist 
can achieve optimal treatment for cholangiocarcinoma, both in cure and in palliation. 
Early detection of cholangiocarcinoma is essential to augment the rate of patients who 
can be treated with a potentially curative resection. 
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SUMMARY 
Gallstones are a major health problem: about 10% of the Western population has 
cholecystolithiasis and about 10% of these patients has choledocholithiasis. 
Chapter 2 of this thesis describes the problems of large, difficult common bile duct stones: 
surgery carries its risks, especially in elderly patients. If endoscopic extraction has been 
attempted but has failed, both surgeon and gastroenterologist are in an awkward position. 
Treatment with ESWL will offer the solution in about 70% of these patients and should be 
undertaken before the decision to operate has been made. 
Chapter 3 describes the quality of life after laparoscopic or conventional cholecystectomy. 
Patients have a quicker improvement of quality of life after a laparoscopic cholecystectomy. 
Chapter 4 tries to temper the euphoria about the laparoscopic cholecystectomy. A good 
randomised trial comparing the laparoscopic with the conventional technique is still not 
published because of this euphoria. Therefore, a group of laparoscopically operated patients 
is matched with historical controls who recently underwent conventional cholecystectomy. 
Although the wellknown advantages of the laparoscopic technique Oess pain. quicker 
discharge from the hospital and quicker return to work) are obvious in this study as well, its 
complications are more serious than those of the conventional technique. 
Through a review of the literature, chapter 5 offers a solution of the problem how to cope 
with eventual stones in the common bile duct when laparoscopic cholecystectomy will be 
undertaken. If on the basis of clinical indicators common bile duct stones are selectively 
removed by means of an endoscope and ESWL, the chance of an unsuspected common bile 
duct stone is small and the chance of it becoming symptomatic even smaller. Following this 
strategy, the number of complications is not higher than that of a surgical exploration of the 
bile ducts. 
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Chapter 6 describes another application of ESWL: the treatment of stones in the pancreatic 
duct in chronic pancreatitis. On short term as well as on long term, the invalidating abdominal 
pain can be successfully treated with ESWL in about 60% of the patients. In this way, an 
operation can be avoided. 
In chapter 7 the role of ESWL in todays pancreatico-biliary surgery is evaluated. Our own 
results and those of other investigators are incorporated. 
Finally, in chapter 8 the treatment of a group of patients with malignant obstruction of the bile 
ducts -cholangiocarcinoma- is evaluated in a retrospective study. A radical operation is, if 
possible, the best treatment with regard to length of survival and possible curation. Only by 
means of close cooperation between surgeon, gastroenterologist, radiologist and radiotherapist 
this tumor can be classified and treated as quick as possible. 
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SAMENV ATTING 
Galstenen vormen een omvangrijk gezondheidsprobleem: ongeveer 10 % van de westerse 
bevolking heeft stenen in de galblaas en ongeveer 10% daarvan heeft stenen in de galwegen. 
Hoofdstuk 2 van dit proefschrift beschrijft de problematiek rond grote, vastzittende stenen in 
de ductus choledochus: de geeigende operatie hiervoor is risicovol, met name bij eeo oudere 
patientenpopulatie. Wanneer dan wordt overgegaan naar een poging tot endoscopische 
extractie en deze blijkt te mislukken, zit zowel chirurg als gastro-enteroloog met de handen 
in het haar. Een ESWL-behandeling biedt dan bij ongeveer 70% van deze patienten uitkomst, 
en zou dus altijd eerst uitgevoerd moeten worden voordat t6ch besloten wordt om te opereren. 
Hoofdstuk 3 beschrijft de kwaliteit van leven, die patienten ervaren na of wei een 
laparoscopische, of een conventionele cholecystectomie. Patienten blijken een snellere 
verbetering van kwaliteit van leven te ervaren na de laparoscopische cholecystectomie. 
Hoofdstuk 4 tracht wat tegengas te geven bij de euforie rond de laparoscopische 
cholecystectomie. Een degelijk, goed gerandomiseerd vergelijkend onderzoek tussen de 
laparoscopische en conventionele techniek is nog niet gepubliceerd vanwege dezelfde euforie. 
Daarom is een groep laparoscopisch geopereerde patienten gekoppeld aan een historische 
controlegroep, welke recent een conventionele cholecystectomie ondergingen. Hoewel de 
overbekende voordelen van de laparoscopische techniek (minder pijn, sneller ontslag uit 
ziekenhuis en snellere hervatting van werk) ook in dit onderzoek duidelijk zijn, blijken de 
complicaties ernstiger dan die van de conventionele techuiek. 
Ondersteund door literatuuronderzoek biedt hoofdstuk 5 een oplossing voor het vraagstuk hoe 
men om moet gaan met eventuele stenen in de ductus choledochus wanneer men een 
laparoscopische cholecystectomie wi! verrichten. Indien op basis van klinische aanwijzingen 
choledochusstenen selectief verwijderd worden met behulp van de endoscoop en ESWL, is 
de kans op een gemiste steen klein en de kans op symptomen door deze steen nog kleiner. Bij 
deze strategie ligt het aantal complicaties ruet duidelijk hoger dan bij een operatie aan de 
galwegen. 
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Hoofdstuk 6 beschrijft een andere toepassing van ESWL: de behandeling van stenen in de 
ductus pancreaticus bij chronische pancreatitis. Zowel op korte als op lange termijn blijkt de 
invaliderende buikpijn bij ongeveer 60% van deze patienten weg te blijven na ESWL-
behandeling. Ben operatie kan op deze manier worden voorkomen. 
In hoofdstuk 7 voIgt een evaluatie van de rol die ESWL in de hedendaagse pancreatico-biliaire 
chirurgie speelt. Daarbij worden de eigen resultaten en die van andere onderzoekers 
meegenomen. 
Tenslotte wordt in hoofdstuk 8 de behandeIing van een groep patienten met maligne obstructie 
van de gaIwegen -het cholangiocarcinoom- geevalueerd in een retrospectief onderzoek. Ben 
radicale operatie is, indien mogelijk, de beste behandeling met de langste overleving en 
rnisschien zelfs genezing. Slechts door een goede samenwerking tussen chirurg. gastro-
enteroloog, radioloog en radiotherapeut kan deze tumor zo snel mogelijk in kaart gebracht en 
behandeld worden. 
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